Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
ASPC.adipocyte_capillary_interface: Meta traits — page 2
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,040 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1,001–2,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1001 | DAB2 levels | PROLV000591 | 1.72 | Protein levels | Lymphocyte | 6 | 3 | 7 | 19 | |
| 1002 | IDS/SMPDL3A ratio | PRORT001330 | 1.72 | Protein ratios | Hepatocyte | 53 | 2 | 8 | 19 | |
| 1003 | Kidney failure, acute | NEPHR000012 | 1.72 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 1004 | CCL13/CCL2 ratio | PRORT000338 | 1.72 | Protein ratios | Myeloid | 8 | 3 | 7 | 10 | |
| 1005 | APPL2 levels | PROLV000130 | 1.72 | Protein levels | Stromal / connective | 3 | 2 | 5 | 8 | |
| 1006 | C-reactive protein | HPBIL000026 | 1.72 | Hepatopancreatobiliary | Hepatocyte | 1,267 | 3 | 10 | 20 | |
| 1007 | MPI levels | PROLV001334 | 1.72 | Protein levels | Stromal / connective | 10 | 5 | 10 | 15 | |
| 1008 | HLA-DRA levels | PROLV000975 | 1.71 | Protein levels | Myeloid | 117 | 3 | 8 | 14 | |
| 1009 | Gout | METBL000043 | 1.71 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 1010 | Temporomandibular joint disorder | MSKEL000022 | 1.71 | Musculoskeletal | Neural / glial | 0 | 1 | 6 | 11 | |
| 1011 | CD200 levels | PROLV000316 | 1.71 | Protein levels | Adipose | 41 | 1 | 7 | 7 | |
| 1012 | MINDY1 levels | PROLV001315 | 1.71 | Protein levels | Stromal / connective | 8 | 3 | 5 | 11 | |
| 1013 | Nerve root disorder | NEURO000030 | 1.70 | Neurologic | Stromal / connective | 3 | 2 | 5 | 15 | |
| 1014 | ADGRE2/B4GALT1 ratio | PRORT000027 | 1.70 | Protein ratios | Myeloid | 57 | 3 | 11 | 23 | |
| 1015 | PRDX5 levels | PROLV001626 | 1.70 | Protein levels | Stromal / connective | 15 | 4 | 10 | 16 | |
| 1016 | Pregnancy complication, haemorrhage | REPRO000030 | 1.70 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 1017 | CD276 levels | PROLV000326 | 1.70 | Protein levels | Adipose | 14 | 0 | 4 | 4 | |
| 1018 | PLXNA4/SKAP2 ratio | PRORT001684 | 1.70 | Protein ratios | Myeloid | 22 | 3 | 8 | 9 | |
| 1019 | TNFSF11 levels | PROLV002076 | 1.69 | Protein levels | Hepatocyte | 28 | 3 | 10 | 14 | |
| 1020 | ANXA3 levels | PROLV000107 | 1.69 | Protein levels | Myeloid | 30 | 4 | 7 | 12 | |
| 1021 | CD93 levels | PROLV000362 | 1.69 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 1022 | Sleep apnoea | RESPI000035 | 1.69 | Respiratory | Neural / glial | 73 | 1 | 2 | 10 | |
| 1023 | FGF5 levels | PROLV000797 | 1.68 | Protein levels | Hepatocyte | 31 | 3 | 5 | 10 | |
| 1024 | TXNDC5 levels | PROLV002125 | 1.68 | Protein levels | Platelet | 15 | 2 | 6 | 20 | |
| 1025 | EFEMP1 levels | PROLV000679 | 1.68 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 1026 | IGFBP4 levels | PROLV001031 | 1.68 | Protein levels | Renal epithelium | 3 | 0 | 6 | 7 | |
| 1027 | AK2 levels | PROLV000071 | 1.68 | Protein levels | Myeloid | 13 | 2 | 5 | 16 | |
| 1028 | TFPI2 levels | PROLV002016 | 1.68 | Protein levels | Myeloid | 105 | 2 | 7 | 15 | |
| 1029 | CRTAC1 levels | PROLV000529 | 1.68 | Protein levels | Myeloid | 136 | 2 | 12 | 16 | |
| 1030 | Lactate | METAB000066 | 1.68 | Metabolites | Myeloid | 0 | 1 | 5 | 10 | |
| 1031 | PEPD levels | PROLV001536 | 1.67 | Protein levels | Myeloid | 66 | 2 | 7 | 7 | |
| 1032 | PPP1R14D levels | PROLV001615 | 1.67 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 1033 | ITGAM levels | PROLV001109 | 1.67 | Protein levels | Myeloid | 94 | 2 | 11 | 15 | |
| 1034 | Peptic ulcer disease | GASTR000051 | 1.67 | Gastrointestinal | Vascular | 12 | 0 | 1 | 5 | |
| 1035 | SKAP2/VSIR ratio | PRORT001788 | 1.67 | Protein ratios | Myeloid | 7 | 4 | 17 | 18 | |
| 1036 | FYN levels | PROLV000843 | 1.67 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 1037 | TIMP1 levels | PROLV002038 | 1.67 | Protein levels | Myeloid | 20 | 2 | 9 | 12 | |
| 1038 | EGF/MGLL ratio | PRORT000996 | 1.66 | Protein ratios | Vascular | 11 | 3 | 8 | 27 | |
| 1039 | SUGT1 levels | PROLV001972 | 1.66 | Protein levels | Myeloid | 38 | 3 | 9 | 14 | |
| 1040 | YTHDF3 levels | PROLV002207 | 1.66 | Protein levels | Myeloid | 27 | 1 | 6 | 6 | |
| 1041 | NXF1 levels | PROLV001457 | 1.65 | Protein levels | Hepatocyte | 2 | 2 | 9 | 20 | |
| 1042 | LGALS1 levels | PROLV001201 | 1.65 | Protein levels | Vascular | 9 | 2 | 4 | 16 | |
| 1043 | POLR2F levels | PROLV001598 | 1.65 | Protein levels | Muscle / cardiac | 1 | 4 | 8 | 22 | |
| 1044 | CD69/SCARF1 ratio | PRORT000497 | 1.64 | Protein ratios | Myeloid | 12 | 3 | 15 | 25 | |
| 1045 | Ascites | HPBIL000020 | 1.64 | Hepatopancreatobiliary | Vascular | 1 | 1 | 7 | 23 | |
| 1046 | FADD levels | PROLV000758 | 1.64 | Protein levels | Stromal / connective | 13 | 3 | 5 | 15 | |
| 1047 | CLMP levels | PROLV000461 | 1.64 | Protein levels | Adipose | 9 | 2 | 6 | 5 | |
| 1048 | Operation, gastrointestinal | GASTR000039 | 1.64 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 1049 | MET/PTPRF ratio | PRORT001520 | 1.64 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 9 | |
| 1050 | STK24 levels | PROLV001964 | 1.64 | Protein levels | Lymphocyte | 2 | 2 | 7 | 21 | |
| 1051 | CD99 levels | PROLV000363 | 1.64 | Protein levels | Granulosa cell | 27 | 1 | 7 | 9 | |
| 1052 | CCL11 levels | PROLV000278 | 1.63 | Protein levels | Vascular | 47 | 0 | 1 | 5 | |
| 1053 | KITLG/PLTP ratio | PRORT001407 | 1.63 | Protein ratios | Hepatocyte | 23 | 1 | 6 | 14 | |
| 1054 | IL15RA levels | PROLV001049 | 1.63 | Protein levels | Lymphocyte | 1 | 0 | 7 | 10 | |
| 1055 | Erysipelas | IMMUN000062 | 1.63 | Immunologic | Hepatocyte | 19 | 2 | 6 | 19 | |
| 1056 | ROR1 levels | PROLV001751 | 1.63 | Protein levels | Hepatocyte | 77 | 1 | 4 | 10 | |
| 1057 | ACVRL1/SCARB2 ratio | PRORT000015 | 1.63 | Protein ratios | Myeloid | 46 | 2 | 9 | 18 | |
| 1058 | MPIG6B/PDGFB ratio | PRORT001557 | 1.63 | Protein ratios | Myeloid | 3 | 4 | 11 | 21 | |
| 1059 | PPP1R14A levels | PROLV001614 | 1.63 | Protein levels | Neural / glial | 11 | 2 | 7 | 11 | |
| 1060 | Respiratory insufficiency | RESPI000031 | 1.62 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 1061 | TIMM8A levels | PROLV002037 | 1.62 | Protein levels | Vascular | 17 | 4 | 8 | 16 | |
| 1062 | GCC1 levels | PROLV000865 | 1.62 | Protein levels | Myeloid | 28 | 2 | 4 | 11 | |
| 1063 | ALDH1A1/CA2 ratio | PRORT000077 | 1.62 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 1064 | SPINK5 levels | PROLV001930 | 1.61 | Protein levels | Renal epithelium | 10 | 1 | 14 | 20 | |
| 1065 | APRT/MIF ratio | PRORT000135 | 1.61 | Protein ratios | Lymphocyte | 2 | 4 | 14 | 40 | |
| 1066 | BTN2A1/LILRB4 ratio | PRORT000258 | 1.61 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 1067 | Cancer, Lung | MALIG000019 | 1.61 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 1068 | ATOX1/SNAP29 ratio | PRORT000151 | 1.61 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 24 | |
| 1069 | DXO levels | PROLV000665 | 1.60 | Protein levels | Lymphocyte | 32 | 5 | 11 | 35 | |
| 1070 | NAA80 levels | PROLV001368 | 1.59 | Protein levels | Vascular | 9 | 3 | 6 | 11 | |
| 1071 | Adhesive capsulitis | MSKEL000058 | 1.59 | Musculoskeletal | Stromal / connective | 26 | 1 | 5 | 13 | |
| 1072 | EGFLAM levels | PROLV000686 | 1.59 | Protein levels | Hepatocyte | 53 | 2 | 10 | 16 | |
| 1073 | HNRNPK levels | PROLV000982 | 1.59 | Protein levels | Lymphocyte | 0 | 4 | 10 | 31 | |
| 1074 | CDC27 levels | PROLV000367 | 1.58 | Protein levels | Lymphocyte | 4 | 3 | 9 | 24 | |
| 1075 | PPP1R2 levels | PROLV001616 | 1.58 | Protein levels | Vascular | 8 | 4 | 8 | 19 | |
| 1076 | COL6A3/NBL1 ratio | PRORT000698 | 1.58 | Protein ratios | Stromal / connective | 29 | 2 | 2 | 8 | |
| 1077 | Amygdala volume | NIMAG000014 | 1.58 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 1078 | DBI levels | PROLV000597 | 1.58 | Protein levels | Stromal / connective | 31 | 5 | 10 | 18 | |
| 1079 | CERT levels | PROLV000404 | 1.58 | Protein levels | Myeloid | 1 | 2 | 11 | 21 | |
| 1080 | ALPI levels | PROLV000082 | 1.58 | Protein levels | Stromal / connective | 4 | 0 | 4 | 21 | |
| 1081 | PTGR1 levels | PROLV001666 | 1.57 | Protein levels | Hepatocyte | 38 | 3 | 11 | 18 | |
| 1082 | Abnormal heart sounds | CARDI000051 | 1.57 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 1083 | RGMB/SMOC2 ratio | PRORT001737 | 1.57 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 1084 | CBLN4/RET ratio | PRORT000326 | 1.57 | Protein ratios | Vascular | 13 | 1 | 8 | 16 | |
| 1085 | CASP3 levels | PROLV000268 | 1.57 | Protein levels | Platelet | 26 | 3 | 9 | 10 | |
| 1086 | Biliary atresia | HPBIL000002 | 1.57 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 1087 | TREML1 levels | PROLV002103 | 1.57 | Protein levels | Lymphocyte | 27 | 2 | 7 | 19 | |
| 1088 | MGMT levels | PROLV001310 | 1.57 | Protein levels | Myeloid | 10 | 4 | 7 | 14 | |
| 1089 | PAK4 levels | PROLV001488 | 1.57 | Protein levels | Myeloid | 1 | 3 | 8 | 16 | |
| 1090 | GFRA3/LAYN ratio | PRORT001211 | 1.56 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 1091 | NFE2 levels | PROLV001397 | 1.56 | Protein levels | Stromal / connective | 10 | 2 | 5 | 12 | |
| 1092 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 1.56 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 1093 | LTBR levels | PROLV001244 | 1.56 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 1094 | AKT3 levels | PROLV000076 | 1.56 | Protein levels | Platelet | 10 | 5 | 10 | 16 | |
| 1095 | CDH3/NECTIN4 ratio | PRORT000554 | 1.55 | Protein ratios | Respiratory epithelium | 19 | 0 | 10 | 9 | |
| 1096 | Memory disorder | PSYCH000006 | 1.55 | Psychiatric | Neural / glial | 1 | 1 | 4 | 8 | |
| 1097 | Chronic viral hepatitis | IMMUN000056 | 1.55 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 1098 | CPQ levels | PROLV000509 | 1.54 | Protein levels | Epithelial | 108 | 2 | 7 | 18 | |
| 1099 | DEFB4A or DEFB4B levels | PROLV000614 | 1.54 | Protein levels | Hepatocyte | 48 | 1 | 7 | 15 | |
| 1100 | CTSL levels | PROLV000566 | 1.54 | Protein levels | Myeloid | 163 | 2 | 9 | 15 | |
| 1101 | IGFBP7 levels | PROLV001033 | 1.54 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 1102 | CORO1A levels | PROLV000499 | 1.54 | Protein levels | Platelet | 2 | 2 | 6 | 14 | |
| 1103 | FTCD levels | PROLV000832 | 1.54 | Protein levels | Hepatocyte | 62 | 1 | 8 | 22 | |
| 1104 | PDGFB/TIMP3 ratio | PRORT001648 | 1.54 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 1105 | PIBF1 levels | PROLV001555 | 1.54 | Protein levels | Vascular | 7 | 1 | 5 | 11 | |
| 1106 | CD99/MMP3 ratio | PRORT000535 | 1.53 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 1107 | KRT8 levels | PROLV001168 | 1.53 | Protein levels | Adipose | 0 | 0 | 3 | 3 | |
| 1108 | ADAM22 levels | PROLV000027 | 1.53 | Protein levels | Adipose | 54 | 0 | 6 | 8 | |
| 1109 | MED18 levels | PROLV001292 | 1.53 | Protein levels | Myeloid | 23 | 5 | 10 | 12 | |
| 1110 | DCN levels | PROLV000601 | 1.53 | Protein levels | Myeloid | 65 | 3 | 10 | 14 | |
| 1111 | SIGLEC9 levels | PROLV001865 | 1.53 | Protein levels | Hepatocyte | 118 | 1 | 6 | 11 | |
| 1112 | CIAPIN1 levels | PROLV000435 | 1.52 | Protein levels | Lymphocyte | 1 | 5 | 9 | 35 | |
| 1113 | ABL1/CC2D1A ratio | PRORT000008 | 1.52 | Protein ratios | Lymphocyte | 4 | 1 | 7 | 21 | |
| 1114 | Gut microbial abundance, Rikenellaceae | GASTR000034 | 1.52 | Gastrointestinal | Neural / glial | 0 | 6 | 10 | 28 | |
| 1115 | BOLA2 or BOLA2B levels | PROLV000208 | 1.52 | Protein levels | Lymphocyte | 3 | 2 | 7 | 24 | |
| 1116 | RABGAP1L levels | PROLV001702 | 1.52 | Protein levels | Muscle / cardiac | 7 | 3 | 10 | 23 | |
| 1117 | MSTN levels | PROLV001345 | 1.52 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 1118 | Gut microbial abundance, Alistipes | GASTR000018 | 1.51 | Gastrointestinal | Neural / glial | 0 | 6 | 11 | 30 | |
| 1119 | CLEC1B/VSIR ratio | PRORT000652 | 1.51 | Protein ratios | Myeloid | 26 | 6 | 14 | 19 | |
| 1120 | AIDA levels | PROLV000067 | 1.51 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 1121 | PDGFA/SPARC ratio | PRORT001637 | 1.51 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 1122 | RABEP1 levels | PROLV001701 | 1.50 | Protein levels | Vascular | 10 | 4 | 10 | 41 | |
| 1123 | MYDGF levels | PROLV001358 | 1.50 | Protein levels | Stromal / connective | 5 | 4 | 9 | 17 | |
| 1124 | Organic acid metabolites | METAB000067 | 1.49 | Metabolites | Pancreatic epithelium | 0 | 0 | 0 | 0 | |
| 1125 | Cereal preference | DTSUP000010 | 1.49 | Diet and Supplement | Neural / glial | 29 | 5 | 9 | 20 | |
| 1126 | CPPED1 levels | PROLV000508 | 1.49 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 12 | |
| 1127 | SMPD1 levels | PROLV001901 | 1.49 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 1128 | CD69/TIA1 ratio | PRORT000500 | 1.49 | Protein ratios | Hepatocyte | 1 | 3 | 9 | 25 | |
| 1129 | CNST/PRKAR1A ratio | PRORT000684 | 1.49 | Protein ratios | Muscle / cardiac | 7 | 3 | 7 | 17 | |
| 1130 | IL16 levels | PROLV001050 | 1.48 | Protein levels | Muscle / cardiac | 38 | 2 | 7 | 27 | |
| 1131 | RHOC/TBCC ratio | PRORT001741 | 1.48 | Protein ratios | Myeloid | 0 | 4 | 10 | 12 | |
| 1132 | FYB1/PPP1R12A ratio | PRORT001199 | 1.48 | Protein ratios | Hepatocyte | 5 | 2 | 9 | 18 | |
| 1133 | Cardiac pacemaker | CARDI000049 | 1.48 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 1134 | Loud music exposure | MISCL000006 | 1.48 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 1135 | RND3 levels | PROLV001743 | 1.47 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 1136 | Childhood maltreatment | PSYCH000052 | 1.47 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 1137 | TIA1 levels | PROLV002032 | 1.46 | Protein levels | Myeloid | 24 | 2 | 4 | 14 | |
| 1138 | CRTAM/TNFRSF9 ratio | PRORT000774 | 1.46 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 1139 | Foot surgery | MSKEL000046 | 1.46 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 1140 | Hypertensive heart disease | CARDI000038 | 1.46 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 1141 | COL1A1 levels | PROLV000485 | 1.46 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 1142 | Vitamin E | METAB000079 | 1.45 | Metabolites | Hepatocyte | 2 | 1 | 5 | 12 | |
| 1143 | ADGRE2 levels | PROLV000043 | 1.45 | Protein levels | Myeloid | 136 | 3 | 10 | 22 | |
| 1144 | RBM17 levels | PROLV001710 | 1.45 | Protein levels | Vascular | 9 | 0 | 3 | 10 | |
| 1145 | FCRL6/GZMA ratio | PRORT001137 | 1.45 | Protein ratios | Lymphocyte | 14 | 2 | 13 | 40 | |
| 1146 | ADGRE5/VCAM1 ratio | PRORT000034 | 1.45 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 1147 | SWAP70 levels | PROLV001983 | 1.45 | Protein levels | Hepatocyte | 3 | 2 | 9 | 12 | |
| 1148 | MITD1/SNX9 ratio | PRORT001537 | 1.44 | Protein ratios | Hepatocyte | 2 | 5 | 13 | 26 | |
| 1149 | TOMM20 levels | PROLV002086 | 1.44 | Protein levels | Stromal / connective | 7 | 4 | 8 | 14 | |
| 1150 | Sepsis | IMMUN000071 | 1.44 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 1151 | NAAA levels | PROLV001369 | 1.44 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 1152 | FUT3 or FUT5 levels | PROLV000838 | 1.44 | Protein levels | Hepatocyte | 85 | 2 | 17 | 39 | |
| 1153 | EGF levels | PROLV000684 | 1.44 | Protein levels | Myeloid | 47 | 2 | 7 | 21 | |
| 1154 | IRAK4 levels | PROLV001098 | 1.44 | Protein levels | Stromal / connective | 19 | 4 | 8 | 17 | |
| 1155 | CXCL17/SFTPA2 ratio | PRORT000824 | 1.44 | Protein ratios | Myeloid | 3 | 2 | 8 | 18 | |
| 1156 | COL9A1 levels | PROLV000493 | 1.44 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 1157 | FUT3 levels | PROLV000837 | 1.43 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 1158 | ALOX15B levels | PROLV000081 | 1.43 | Protein levels | Lymphocyte | 0 | 6 | 11 | 37 | |
| 1159 | MMP8/PGLYRP1 ratio | PRORT001544 | 1.43 | Protein ratios | Myeloid | 15 | 5 | 9 | 13 | |
| 1160 | Lactase deficiency | METBL000002 | 1.43 | Metabolic | Vascular | 0 | 2 | 5 | 12 | |
| 1161 | CTHRC1 levels | PROLV000556 | 1.43 | Protein levels | Myeloid | 27 | 4 | 11 | 12 | |
| 1162 | Hair characteristics | DERMA000031 | 1.43 | Dermatologic | Adipose | 1 | 1 | 1 | 0 | |
| 1163 | FURIN/INHBC ratio | PRORT001184 | 1.43 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 23 | |
| 1164 | Upper respiratory inflammation | RESPI000041 | 1.43 | Respiratory | Muscle / cardiac | 1 | 1 | 1 | 9 | |
| 1165 | Mononeuropathy | NEURO000027 | 1.43 | Neurologic | Stromal / connective | 2 | 0 | 0 | 3 | |
| 1166 | Intervertebral disc disorder | MSKEL000076 | 1.43 | Musculoskeletal | Stromal / connective | 31 | 2 | 6 | 23 | |
| 1167 | PAXX levels | PROLV001499 | 1.43 | Protein levels | Lymphocyte | 14 | 4 | 15 | 31 | |
| 1168 | Uterine or vaginal bleeding | REPRO000044 | 1.42 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 1169 | Family history, lung cancer | MALIG000039 | 1.42 | Malignancy | Lymphocyte | 7 | 2 | 7 | 21 | |
| 1170 | Urinary tract infection | IMMUN000074 | 1.42 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 1171 | GRAP2 levels | PROLV000931 | 1.42 | Protein levels | Platelet | 6 | 7 | 9 | 18 | |
| 1172 | LY6D/NECTIN4 ratio | PRORT001468 | 1.42 | Protein ratios | Cutaneous epithelium | 13 | 0 | 8 | 11 | |
| 1173 | CLEC1B levels | PROLV000448 | 1.42 | Protein levels | Lymphocyte | 35 | 2 | 9 | 25 | |
| 1174 | Liver enzyme levels, ALP | HPBIL000012 | 1.41 | Hepatopancreatobiliary | Hepatocyte | 1,521 | 1 | 5 | 16 | |
| 1175 | TBC1D23 levels | PROLV001996 | 1.41 | Protein levels | Muscle / cardiac | 15 | 2 | 8 | 18 | |
| 1176 | GTPBP2 levels | PROLV000944 | 1.41 | Protein levels | Lymphocyte | 6 | 4 | 9 | 17 | |
| 1177 | AP1G2 levels | PROLV000110 | 1.41 | Protein levels | Stromal / connective | 14 | 2 | 5 | 12 | |
| 1178 | CELA3A/CPB1 ratio | PRORT000594 | 1.41 | Protein ratios | Vascular | 26 | 1 | 3 | 10 | |
| 1179 | ASRGL1 levels | PROLV000155 | 1.40 | Protein levels | Myeloid | 13 | 3 | 6 | 15 | |
| 1180 | TNFRSF14/TNFRSF1A ratio | PRORT001850 | 1.40 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 27 | |
| 1181 | Ocular alignment disorder | OPHTH000023 | 1.40 | Ophthalmic | Myeloid | 9 | 4 | 9 | 17 | |
| 1182 | CASP8/RILP ratio | PRORT000324 | 1.40 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 1183 | Blood pressure, BP, arterial | VASCU000007 | 1.40 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 1184 | Acne | DERMA000028 | 1.40 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 1185 | RGS10 levels | PROLV001730 | 1.40 | Protein levels | Myeloid | 2 | 3 | 6 | 15 | |
| 1186 | FCGR3B levels | PROLV000780 | 1.40 | Protein levels | Myeloid | 115 | 2 | 9 | 12 | |
| 1187 | CLEC1A/GPR37 ratio | PRORT000631 | 1.40 | Protein ratios | Muscle / cardiac | 25 | 3 | 8 | 20 | |
| 1188 | Fatty acids unsaturation | LIPID000032 | 1.40 | Lipids | Hepatocyte | 1,087 | 2 | 7 | 16 | |
| 1189 | Cholesteryl esters | LIPID000019 | 1.40 | Lipids | Neural / glial | 42 | 2 | 4 | 15 | |
| 1190 | NTF3 levels | PROLV001442 | 1.40 | Protein levels | Vascular | 1 | 3 | 8 | 14 | |
| 1191 | RAB27B levels | PROLV001697 | 1.39 | Protein levels | Myeloid | 28 | 2 | 4 | 11 | |
| 1192 | CD55/ITGB1 ratio | PRORT000470 | 1.39 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 1193 | Testicular dysfunction | REPRO000016 | 1.39 | Reproductive | Hepatocyte | 14 | 3 | 12 | 33 | |
| 1194 | ARHGAP1 levels | PROLV000135 | 1.38 | Protein levels | Myeloid | 5 | 1 | 8 | 12 | |
| 1195 | RNF41 levels | PROLV001746 | 1.38 | Protein levels | Stromal / connective | 0 | 1 | 6 | 10 | |
| 1196 | PTN levels | PROLV001669 | 1.38 | Protein levels | Hepatocyte | 35 | 5 | 12 | 30 | |
| 1197 | CD69/SNAP23 ratio | PRORT000498 | 1.38 | Protein ratios | Hematopoietic progenitor | 1 | 3 | 9 | 21 | |
| 1198 | DUT levels | PROLV000664 | 1.38 | Protein levels | Myeloid | 6 | 3 | 6 | 11 | |
| 1199 | FKBP14 levels | PROLV000807 | 1.37 | Protein levels | Myeloid | 20 | 3 | 6 | 16 | |
| 1200 | TMSB10 levels | PROLV002051 | 1.37 | Protein levels | Myeloid | 12 | 3 | 7 | 18 | |
| 1201 | CMIP levels | PROLV000470 | 1.37 | Protein levels | Stromal / connective | 1 | 2 | 6 | 11 | |
| 1202 | IGFBP6/MFAP5 ratio | PRORT001336 | 1.37 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 1203 | NID1/TIMP3 ratio | PRORT001590 | 1.37 | Protein ratios | Vascular | 24 | 1 | 7 | 11 | |
| 1204 | HLA-E levels | PROLV000976 | 1.36 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 1205 | PDLIM5 levels | PROLV001528 | 1.36 | Protein levels | Stromal / connective | 1 | 3 | 13 | 30 | |
| 1206 | NEXN levels | PROLV001393 | 1.36 | Protein levels | Vascular | 1 | 2 | 3 | 9 | |
| 1207 | MANF levels | PROLV001262 | 1.36 | Protein levels | Myeloid | 26 | 4 | 7 | 20 | |
| 1208 | PRDX3 levels | PROLV001625 | 1.35 | Protein levels | Myeloid | 11 | 2 | 7 | 12 | |
| 1209 | PRKRA levels | PROLV001634 | 1.35 | Protein levels | Myeloid | 4 | 4 | 8 | 23 | |
| 1210 | CCL16 levels | PROLV000282 | 1.35 | Protein levels | Hepatocyte | 117 | 2 | 8 | 16 | |
| 1211 | Iron deficiency anaemia | HEMAT000011 | 1.35 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 1212 | EVI5 levels | PROLV000737 | 1.35 | Protein levels | Myeloid | 1 | 2 | 8 | 16 | |
| 1213 | MOCS2 levels | PROLV001331 | 1.35 | Protein levels | Stromal / connective | 8 | 1 | 3 | 21 | |
| 1214 | NOTCH1 levels | PROLV001416 | 1.35 | Protein levels | Hepatocyte | 100 | 2 | 7 | 17 | |
| 1215 | ICAM5 levels | PROLV001008 | 1.35 | Protein levels | Myeloid | 6 | 0 | 3 | 9 | |
| 1216 | PILRB levels | PROLV001561 | 1.35 | Protein levels | Myeloid | 43 | 2 | 6 | 10 | |
| 1217 | EPO/TFRC ratio | PRORT001040 | 1.35 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 1218 | BID levels | PROLV000195 | 1.35 | Protein levels | Myeloid | 15 | 3 | 7 | 16 | |
| 1219 | Otosclerosis | AUDIO000018 | 1.34 | Auditory | Granulosa cell | 16 | 5 | 10 | 16 | |
| 1220 | MSRA/SNAP29 ratio | PRORT001563 | 1.34 | Protein ratios | Myeloid | 14 | 4 | 10 | 15 | |
| 1221 | DCTD levels | PROLV000602 | 1.34 | Protein levels | Stromal / connective | 0 | 4 | 7 | 12 | |
| 1222 | P4HB levels | PROLV001481 | 1.34 | Protein levels | Stromal / connective | 66 | 2 | 7 | 26 | |
| 1223 | S100A16 levels | PROLV001770 | 1.34 | Protein levels | Vascular | 10 | 0 | 4 | 9 | |
| 1224 | CDKN1A levels | PROLV000382 | 1.34 | Protein levels | Vascular | 59 | 1 | 5 | 13 | |
| 1225 | Ischaemic stroke | VASCU000015 | 1.34 | Vascular | Muscle / cardiac | 4 | 3 | 8 | 13 | |
| 1226 | APRT/PSME1 ratio | PRORT000137 | 1.34 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 1227 | Smoking dependency | PSYCH000047 | 1.33 | Psychiatric | Neural / glial | 0 | 5 | 7 | 16 | |
| 1228 | BCL2L2 levels | PROLV000189 | 1.33 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 1229 | Bone marrow fat fraction, spine | MSKEL000002 | 1.33 | Musculoskeletal | Vascular | 67 | 2 | 8 | 16 | |
| 1230 | AZU1/MPO ratio | PRORT000185 | 1.33 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 1231 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 1.33 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 1232 | CRKL/FIS1 ratio | PRORT000763 | 1.33 | Protein ratios | Hepatocyte | 1 | 1 | 12 | 15 | |
| 1233 | Drug response, carboplatin | MALIG000047 | 1.33 | Malignancy | Lymphocyte | 0 | 1 | 9 | 27 | |
| 1234 | SRP14 levels | PROLV001943 | 1.33 | Protein levels | Lymphocyte | 4 | 2 | 14 | 26 | |
| 1235 | BAG3 levels | PROLV000174 | 1.33 | Protein levels | Hepatocyte | 73 | 1 | 4 | 12 | |
| 1236 | DNAJB14 levels | PROLV000631 | 1.32 | Protein levels | Muscle / cardiac | 12 | 2 | 3 | 16 | |
| 1237 | DCTN1/ERBIN ratio | PRORT000871 | 1.32 | Protein ratios | Hepatocyte | 0 | 4 | 13 | 21 | |
| 1238 | STAB2 levels | PROLV001956 | 1.32 | Protein levels | Granulosa cell | 78 | 2 | 11 | 19 | |
| 1239 | CLEC14A/EPHB4 ratio | PRORT000626 | 1.32 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 1240 | RWDD1/SUMF2 ratio | PRORT001752 | 1.32 | Protein ratios | Hepatocyte | 39 | 2 | 5 | 10 | |
| 1241 | Kidney volume | NEPHR000022 | 1.32 | Nephrourologic | Stromal / connective | 1 | 3 | 8 | 25 | |
| 1242 | Cellulitis and abscess | IMMUN000055 | 1.32 | Immunologic | Neural / glial | 5 | 4 | 11 | 20 | |
| 1243 | CTSZ/SMPDL3A ratio | PRORT000806 | 1.31 | Protein ratios | Hepatocyte | 34 | 4 | 10 | 17 | |
| 1244 | JAM2/TNFRSF21 ratio | PRORT001401 | 1.31 | Protein ratios | Vascular | 4 | 1 | 6 | 7 | |
| 1245 | PCDHB15 levels | PROLV001509 | 1.31 | Protein levels | Vascular | 46 | 2 | 6 | 9 | |
| 1246 | GLOD4 levels | PROLV000896 | 1.31 | Protein levels | Vascular | 2 | 4 | 10 | 31 | |
| 1247 | YARS1 levels | PROLV002203 | 1.31 | Protein levels | Stromal / connective | 1 | 4 | 7 | 20 | |
| 1248 | AKR7L levels | PROLV000073 | 1.30 | Protein levels | Hepatocyte | 29 | 3 | 9 | 22 | |
| 1249 | SERPINF1 levels | PROLV001832 | 1.30 | Protein levels | Vascular | 7 | 0 | 6 | 8 | |
| 1250 | ADGRE2/IFNGR1 ratio | PRORT000029 | 1.30 | Protein ratios | Myeloid | 51 | 2 | 10 | 15 | |
| 1251 | PAPL levels | PROLV001494 | 1.30 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 1252 | JAM2 levels | PROLV001124 | 1.30 | Protein levels | Vascular | 4 | 0 | 5 | 7 | |
| 1253 | ERBB2 levels | PROLV000724 | 1.30 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 1254 | Phospholipid species | LIPID000064 | 1.30 | Lipids | Hepatocyte | 23 | 2 | 4 | 16 | |
| 1255 | NTPROBNP levels | PROLV001446 | 1.29 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 1256 | CDH5/TEK ratio | PRORT000561 | 1.29 | Protein ratios | Vascular | 42 | 2 | 8 | 11 | |
| 1257 | ACVRL1/EFNA4 ratio | PRORT000014 | 1.29 | Protein ratios | Vascular | 35 | 4 | 10 | 14 | |
| 1258 | TSC22D1 levels | PROLV002113 | 1.29 | Protein levels | Stromal / connective | 4 | 2 | 9 | 10 | |
| 1259 | DOK2 levels | PROLV000642 | 1.29 | Protein levels | Platelet | 24 | 4 | 9 | 11 | |
| 1260 | Bacterial intestinal infection | IMMUN000052 | 1.29 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 1261 | SFRP1 levels | PROLV001844 | 1.29 | Protein levels | Vascular | 20 | 3 | 6 | 17 | |
| 1262 | NRCAM/NTRK2 ratio | PRORT001597 | 1.29 | Protein ratios | Myeloid | 0 | 2 | 11 | 18 | |
| 1263 | CIAPIN1/SNX9 ratio | PRORT000617 | 1.29 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 1264 | LAT/LYN ratio | PRORT001422 | 1.29 | Protein ratios | Lymphocyte | 0 | 2 | 17 | 49 | |
| 1265 | ACY1/GSTA1 ratio | PRORT000020 | 1.28 | Protein ratios | Hepatocyte | 61 | 3 | 12 | 27 | |
| 1266 | GOPC levels | PROLV000910 | 1.28 | Protein levels | Myeloid | 27 | 1 | 7 | 15 | |
| 1267 | Body water mass | BCOMP000006 | 1.28 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 1268 | PLXNA4 levels | PROLV001585 | 1.28 | Protein levels | Lymphocyte | 41 | 2 | 5 | 19 | |
| 1269 | PROC levels | PROLV001637 | 1.28 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 1270 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 1.28 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 1271 | CPXM1/LGMN ratio | PRORT000734 | 1.28 | Protein ratios | Platelet | 10 | 3 | 6 | 11 | |
| 1272 | Spine surgery | MSKEL000051 | 1.28 | Musculoskeletal | Stromal / connective | 0 | 2 | 7 | 14 | |
| 1273 | Joint disorder | MSKEL000015 | 1.28 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 1274 | DGKA levels | PROLV000616 | 1.27 | Protein levels | Lymphocyte | 0 | 1 | 10 | 32 | |
| 1275 | VPS37A levels | PROLV002166 | 1.27 | Protein levels | Hepatocyte | 40 | 2 | 6 | 17 | |
| 1276 | VASN levels | PROLV002151 | 1.27 | Protein levels | Hepatocyte | 136 | 1 | 7 | 11 | |
| 1277 | SYTL4 levels | PROLV001986 | 1.27 | Protein levels | Myeloid | 17 | 3 | 7 | 18 | |
| 1278 | BCL2L1 levels | PROLV000186 | 1.27 | Protein levels | Myeloid | 28 | 3 | 6 | 13 | |
| 1279 | GALNT10/IGSF3 ratio | PRORT001201 | 1.27 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 1280 | CA1/CA2 ratio | PRORT000267 | 1.27 | Protein ratios | Muscle / cardiac | 0 | 1 | 7 | 11 | |
| 1281 | CACYBP levels | PROLV000252 | 1.27 | Protein levels | Platelet | 2 | 4 | 7 | 21 | |
| 1282 | DCBLD2 levels | PROLV000600 | 1.27 | Protein levels | Hepatocyte | 264 | 3 | 13 | 20 | |
| 1283 | Sciatica | NEURO000033 | 1.27 | Neurologic | Neural / glial | 12 | 6 | 11 | 26 | |
| 1284 | Brain age gap | NIMAG000004 | 1.27 | Neuroimaging | Neural / glial | 1 | 4 | 15 | 36 | |
| 1285 | F11R levels | PROLV000742 | 1.27 | Protein levels | Lymphocyte | 31 | 2 | 10 | 21 | |
| 1286 | TNFRSF11B levels | PROLV002061 | 1.27 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 1287 | NCAM1 levels | PROLV001377 | 1.26 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 1288 | COMP levels | PROLV000496 | 1.26 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 1289 | DCTN1/FXN ratio | PRORT000872 | 1.26 | Protein ratios | Hepatocyte | 0 | 4 | 15 | 34 | |
| 1290 | ARHGAP25 levels | PROLV000136 | 1.26 | Protein levels | Hepatocyte | 6 | 0 | 2 | 7 | |
| 1291 | Immune cell marker, CD8 T cell | HEMAT000023 | 1.26 | Hematologic | Lymphocyte | 17 | 2 | 18 | 40 | |
| 1292 | ALCAM/IL1RL2 ratio | PRORT000072 | 1.26 | Protein ratios | Hepatocyte | 53 | 1 | 9 | 17 | |
| 1293 | Medication, beta blocker | VASCU000034 | 1.26 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 1294 | IMPACT levels | PROLV001085 | 1.26 | Protein levels | Muscle / cardiac | 1 | 5 | 11 | 38 | |
| 1295 | TPPP3 levels | PROLV002098 | 1.25 | Protein levels | Muscle / cardiac | 4 | 2 | 4 | 8 | |
| 1296 | ERBIN levels | PROLV000727 | 1.25 | Protein levels | Neural / glial | 8 | 6 | 6 | 10 | |
| 1297 | PHACTR2 levels | PROLV001549 | 1.25 | Protein levels | Myeloid | 24 | 2 | 5 | 13 | |
| 1298 | JAM3 levels | PROLV001125 | 1.25 | Protein levels | Lymphocyte | 3 | 2 | 6 | 17 | |
| 1299 | ECG morphology, unadjusted | ECGRM000002 | 1.25 | Electrocardiogram | Muscle / cardiac | 478 | 2 | 4 | 6 | |
| 1300 | DAAM1 levels | PROLV000590 | 1.25 | Protein levels | Myeloid | 41 | 1 | 4 | 19 | |
| 1301 | LRP1 levels | PROLV001229 | 1.24 | Protein levels | Myeloid | 175 | 3 | 9 | 19 | |
| 1302 | Primary sclerosing cholangitis, PSC | IMMUN000018 | 1.24 | Immunologic | B / plasma cell | 90 | 3 | 12 | 15 | |
| 1303 | Membranous nephropathy | NEPHR000008 | 1.24 | Nephrourologic | Myeloid | 15 | 7 | 16 | 25 | |
| 1304 | NCR3LG1 levels | PROLV001384 | 1.24 | Protein levels | Hepatocyte | 32 | 1 | 8 | 15 | |
| 1305 | Progesterone metabolite | METAB000072 | 1.24 | Metabolites | Hepatocyte | 13 | 1 | 6 | 18 | |
| 1306 | EIF4B levels | PROLV000695 | 1.23 | Protein levels | Stromal / connective | 2 | 3 | 6 | 31 | |
| 1307 | FLRT2/GFRA3 ratio | PRORT001161 | 1.23 | Protein ratios | Granulosa cell | 18 | 2 | 10 | 21 | |
| 1308 | CLIP2 levels | PROLV000459 | 1.23 | Protein levels | Vascular | 19 | 1 | 5 | 9 | |
| 1309 | Leucine | METAB000025 | 1.23 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 1310 | COMP/ITGAV ratio | PRORT000711 | 1.23 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 1311 | FCRL2/KLB ratio | PRORT001129 | 1.23 | Protein ratios | Hepatocyte | 35 | 1 | 5 | 11 | |
| 1312 | Implantable cardioverter-defibrillator | CARDI000050 | 1.23 | Cardiac | Muscle / cardiac | 18 | 2 | 5 | 10 | |
| 1313 | CNDP1 levels | PROLV000471 | 1.23 | Protein levels | Hepatocyte | 75 | 2 | 12 | 12 | |
| 1314 | DTYMK levels | PROLV000661 | 1.23 | Protein levels | Lymphocyte | 6 | 3 | 9 | 30 | |
| 1315 | GRN levels | PROLV000933 | 1.23 | Protein levels | Myeloid | 36 | 1 | 4 | 9 | |
| 1316 | Lysine metabolites | METAB000009 | 1.23 | Metabolites | Lymphocyte | 6 | 1 | 3 | 20 | |
| 1317 | IST1 levels | PROLV001103 | 1.22 | Protein levels | Myeloid | 20 | 2 | 4 | 15 | |
| 1318 | FAM151A levels | PROLV000760 | 1.22 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 1319 | CD46/TNFRSF14 ratio | PRORT000462 | 1.22 | Protein ratios | Vascular | 21 | 1 | 4 | 10 | |
| 1320 | SLC51B levels | PROLV001883 | 1.22 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 1321 | GHR levels | PROLV000885 | 1.22 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 1322 | ERBB2/FURIN ratio | PRORT001042 | 1.22 | Protein ratios | Hepatocyte | 39 | 2 | 7 | 17 | |
| 1323 | DPP10 levels | PROLV000645 | 1.21 | Protein levels | Vascular | 10 | 2 | 9 | 19 | |
| 1324 | EDIL3 levels | PROLV000675 | 1.21 | Protein levels | Lymphocyte | 4 | 2 | 10 | 30 | |
| 1325 | FKBP1B/TGFB1 ratio | PRORT001152 | 1.21 | Protein ratios | Myeloid | 4 | 3 | 12 | 26 | |
| 1326 | Cancer, Oesophagus | MALIG000021 | 1.21 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 1327 | GPNMB levels | PROLV000927 | 1.21 | Protein levels | Hepatocyte | 49 | 5 | 9 | 24 | |
| 1328 | MPO levels | PROLV001336 | 1.21 | Protein levels | Myeloid | 55 | 2 | 5 | 10 | |
| 1329 | ENG/NCAM2 ratio | PRORT001017 | 1.21 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 6 | 15 | |
| 1330 | MFAP5 levels | PROLV001306 | 1.21 | Protein levels | Vascular | 14 | 2 | 7 | 13 | |
| 1331 | SIRT2 levels | PROLV001870 | 1.21 | Protein levels | Myeloid | 30 | 5 | 9 | 17 | |
| 1332 | FGFBP2 levels | PROLV000799 | 1.20 | Protein levels | Myeloid | 82 | 3 | 11 | 17 | |
| 1333 | Digestive system disorder | GASTR000006 | 1.20 | Gastrointestinal | Vascular | 60 | 0 | 7 | 16 | |
| 1334 | Male genital disorder | REPRO000013 | 1.20 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 1335 | MESD/SNX9 ratio | PRORT001517 | 1.20 | Protein ratios | Stromal / connective | 1 | 5 | 10 | 28 | |
| 1336 | CCL11/CCL2 ratio | PRORT000335 | 1.20 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 1337 | VWA1 levels | PROLV002179 | 1.20 | Protein levels | Hepatocyte | 83 | 2 | 10 | 14 | |
| 1338 | PLIN3 levels | PROLV001579 | 1.20 | Protein levels | Muscle / cardiac | 0 | 6 | 11 | 22 | |
| 1339 | MESD levels | PROLV001301 | 1.20 | Protein levels | Platelet | 9 | 6 | 7 | 11 | |
| 1340 | Medication, proton pump inhibitor | GASTR000017 | 1.20 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 1341 | DKK4/REG1B ratio | PRORT000910 | 1.20 | Protein ratios | Hepatocyte | 27 | 1 | 10 | 15 | |
| 1342 | PCDH7 levels | PROLV001507 | 1.20 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 1343 | PLAUR/TREM2 ratio | PRORT001680 | 1.20 | Protein ratios | Hepatocyte | 73 | 3 | 12 | 16 | |
| 1344 | CRADD/EREG ratio | PRORT000744 | 1.20 | Protein ratios | Myeloid | 1 | 3 | 9 | 17 | |
| 1345 | CD69/CEP43 ratio | PRORT000488 | 1.20 | Protein ratios | Myeloid | 0 | 1 | 6 | 10 | |
| 1346 | Osteoarthritis, OA | MSKEL000012 | 1.19 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 1347 | Brain structural connectivity | NIMAG000007 | 1.19 | Neuroimaging | Neural / glial | 35 | 0 | 0 | 0 | |
| 1348 | DKK4 levels | PROLV000622 | 1.19 | Protein levels | Vascular | 53 | 2 | 10 | 18 | |
| 1349 | DMP1 levels | PROLV000628 | 1.19 | Protein levels | Myeloid | 89 | 3 | 8 | 11 | |
| 1350 | LGALS8/SOD2 ratio | PRORT001453 | 1.19 | Protein ratios | Myeloid | 6 | 6 | 16 | 28 | |
| 1351 | Hypertension | VASCU000027 | 1.19 | Vascular | Vascular | 668 | 3 | 5 | 11 | |
| 1352 | SCAMP3/STX4 ratio | PRORT001756 | 1.19 | Protein ratios | Vascular | 3 | 2 | 8 | 11 | |
| 1353 | CD22/CD79B ratio | PRORT000399 | 1.19 | Protein ratios | B / plasma cell | 16 | 1 | 7 | 10 | |
| 1354 | NSFL1C/PSMG3 ratio | PRORT001599 | 1.18 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 1355 | DSG3/DSG4 ratio | PRORT000952 | 1.18 | Protein ratios | Cutaneous epithelium | 11 | 1 | 6 | 11 | |
| 1356 | MAP4K5 levels | PROLV001269 | 1.17 | Protein levels | Stromal / connective | 21 | 3 | 9 | 10 | |
| 1357 | FXYD5 levels | PROLV000841 | 1.17 | Protein levels | Myeloid | 24 | 4 | 11 | 19 | |
| 1358 | MAVS levels | PROLV001279 | 1.17 | Protein levels | Myeloid | 7 | 3 | 3 | 11 | |
| 1359 | Triglycerides/phosphoglycerides | LIPID000042 | 1.17 | Lipids | Hepatocyte | 839 | 3 | 8 | 17 | |
| 1360 | Metabolon metabolite | METAB000076 | 1.17 | Metabolites | Hepatocyte | 164 | 1 | 2 | 11 | |
| 1361 | PRKAR1A levels | PROLV001631 | 1.17 | Protein levels | Platelet | 0 | 5 | 11 | 23 | |
| 1362 | PDE5A levels | PROLV001520 | 1.17 | Protein levels | Muscle / cardiac | 19 | 2 | 8 | 18 | |
| 1363 | SCAMP3 levels | PROLV001778 | 1.17 | Protein levels | Vascular | 15 | 2 | 4 | 12 | |
| 1364 | LAT/MANF ratio | PRORT001423 | 1.17 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 14 | |
| 1365 | LAT levels | PROLV001184 | 1.17 | Protein levels | Myeloid | 41 | 2 | 5 | 16 | |
| 1366 | OTUD6B levels | PROLV001477 | 1.16 | Protein levels | Lymphocyte | 13 | 2 | 6 | 19 | |
| 1367 | SMOC2 levels | PROLV001900 | 1.16 | Protein levels | Stromal / connective | 4 | 0 | 1 | 2 | |
| 1368 | LTBP3 levels | PROLV001243 | 1.16 | Protein levels | Hepatocyte | 52 | 1 | 8 | 19 | |
| 1369 | COL5A1 levels | PROLV000491 | 1.16 | Protein levels | Myeloid | 47 | 1 | 6 | 11 | |
| 1370 | TNFAIP2 levels | PROLV002054 | 1.16 | Protein levels | Myeloid | 10 | 2 | 4 | 10 | |
| 1371 | TMSB10/TRIAP1 ratio | PRORT001840 | 1.16 | Protein ratios | Myeloid | 2 | 3 | 7 | 14 | |
| 1372 | PPP1R9B levels | PROLV001617 | 1.15 | Protein levels | Vascular | 18 | 2 | 5 | 15 | |
| 1373 | NTN1 levels | PROLV001444 | 1.15 | Protein levels | B / plasma cell | 0 | 1 | 3 | 14 | |
| 1374 | LIFR levels | PROLV001210 | 1.15 | Protein levels | Vascular | 75 | 4 | 12 | 46 | |
| 1375 | CD58 levels | PROLV000346 | 1.15 | Protein levels | Granulosa cell | 82 | 2 | 7 | 13 | |
| 1376 | Dyslipidaemia | METBL000020 | 1.15 | Metabolic | Hepatocyte | 416 | 1 | 6 | 10 | |
| 1377 | TNFRSF10A levels | PROLV002057 | 1.15 | Protein levels | Myeloid | 46 | 1 | 7 | 5 | |
| 1378 | Dihexosylceramides | LIPID000066 | 1.15 | Lipids | Neural / glial | 1 | 1 | 2 | 7 | |
| 1379 | Osteochondrodysplasia | MSKEL000054 | 1.15 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 | |
| 1380 | TARBP2 levels | PROLV001993 | 1.15 | Protein levels | Vascular | 16 | 2 | 6 | 19 | |
| 1381 | HYOU1/ROR1 ratio | PRORT001316 | 1.15 | Protein ratios | Hepatocyte | 41 | 1 | 6 | 6 | |
| 1382 | ROBO2/SFTPD ratio | PRORT001746 | 1.15 | Protein ratios | Neural / glial | 15 | 1 | 5 | 19 | |
| 1383 | ATXN10 levels | PROLV000164 | 1.15 | Protein levels | Vascular | 7 | 3 | 9 | 20 | |
| 1384 | SPINT1 levels | PROLV001932 | 1.14 | Protein levels | Cutaneous epithelium | 74 | 0 | 5 | 11 | |
| 1385 | IGSF9 levels | PROLV001040 | 1.14 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 1386 | Body size, birth | BMORP000017 | 1.14 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 1387 | S100A14 levels | PROLV001769 | 1.14 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 1388 | Cardiovascular disease, none | CARDI000034 | 1.14 | Cardiac | Vascular | 201 | 2 | 5 | 9 | |
| 1389 | BCL2L15 levels | PROLV000188 | 1.14 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 1390 | MEGF10 levels | PROLV001293 | 1.14 | Protein levels | Muscle / cardiac | 25 | 4 | 11 | 30 | |
| 1391 | MANF/PTPN6 ratio | PRORT001479 | 1.14 | Protein ratios | Muscle / cardiac | 9 | 1 | 5 | 13 | |
| 1392 | Corns and callosities | DERMA000023 | 1.14 | Dermatologic | Cutaneous epithelium | 3 | 0 | 3 | 3 | |
| 1393 | ALCAM/MSR1 ratio | PRORT000074 | 1.14 | Protein ratios | Myeloid | 30 | 2 | 10 | 13 | |
| 1394 | HMOX2/TDRKH ratio | PRORT001291 | 1.14 | Protein ratios | Stromal / connective | 0 | 3 | 7 | 16 | |
| 1395 | SUSD1 levels | PROLV001978 | 1.14 | Protein levels | Vascular | 27 | 4 | 5 | 14 | |
| 1396 | Triglycerides, total | LIPID000037 | 1.14 | Lipids | Hepatocyte | 2,195 | 3 | 7 | 16 | |
| 1397 | DSC2/SPINT1 ratio | PRORT000951 | 1.14 | Protein ratios | Epithelial | 23 | 0 | 7 | 3 | |
| 1398 | CA1/HMBS ratio | PRORT000269 | 1.14 | Protein ratios | Lymphocyte | 14 | 4 | 20 | 40 | |
| 1399 | Hip joint morphology | MSKEL000023 | 1.13 | Musculoskeletal | Stromal / connective | 56 | 2 | 4 | 7 | |
| 1400 | IL19 levels | PROLV001058 | 1.13 | Protein levels | Vascular | 20 | 0 | 7 | 23 | |
| 1401 | ITGA5/LILRA2 ratio | PRORT001371 | 1.13 | Protein ratios | Hepatocyte | 38 | 3 | 12 | 20 | |
| 1402 | BCHE levels | PROLV000184 | 1.13 | Protein levels | Hepatocyte | 114 | 1 | 5 | 11 | |
| 1403 | MASP1 levels | PROLV001276 | 1.13 | Protein levels | Hepatocyte | 99 | 1 | 7 | 7 | |
| 1404 | Eustachian tube disorder | AUDIO000015 | 1.12 | Auditory | Epithelial | 0 | 0 | 6 | 8 | |
| 1405 | IL22 levels | PROLV001066 | 1.12 | Protein levels | Melanocyte | 14 | 1 | 6 | 12 | |
| 1406 | F7/F9 ratio | PRORT001087 | 1.12 | Protein ratios | Hepatocyte | 55 | 1 | 12 | 14 | |
| 1407 | Arthropathy | MSKEL000013 | 1.12 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 1408 | SNAP23 levels | PROLV001905 | 1.12 | Protein levels | Platelet | 23 | 2 | 5 | 16 | |
| 1409 | CDCP1/MSR1 ratio | PRORT000544 | 1.12 | Protein ratios | Myeloid | 26 | 2 | 10 | 13 | |
| 1410 | Cerebral aneurysm | VASCU000004 | 1.12 | Vascular | Vascular | 0 | 0 | 1 | 5 | |
| 1411 | COLEC12/LTBR ratio | PRORT000703 | 1.11 | Protein ratios | Myeloid | 50 | 3 | 7 | 12 | |
| 1412 | PTPN1/SCAMP3 ratio | PRORT001716 | 1.11 | Protein ratios | Vascular | 11 | 3 | 9 | 14 | |
| 1413 | ATG16L1 levels | PROLV000158 | 1.11 | Protein levels | Stromal / connective | 26 | 1 | 4 | 9 | |
| 1414 | Sugar alcohols | METAB000037 | 1.11 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 1415 | ANKMY2 levels | PROLV000100 | 1.11 | Protein levels | Stromal / connective | 7 | 3 | 7 | 9 | |
| 1416 | CD40LG levels | PROLV000341 | 1.11 | Protein levels | Myeloid | 31 | 4 | 7 | 15 | |
| 1417 | Cancer, Breast | MALIG000011 | 1.11 | Malignancy | Cutaneous epithelium | 47 | 1 | 8 | 13 | |
| 1418 | Sphingomyelins | LIPID000072 | 1.11 | Lipids | Hepatocyte | 272 | 1 | 2 | 8 | |
| 1419 | Autoimmune hepatitis | IMMUN000024 | 1.11 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 1420 | Cardiomyopathy | CARDI000040 | 1.11 | Cardiac | Muscle / cardiac | 51 | 2 | 3 | 3 | |
| 1421 | FIS1/PDGFB ratio | PRORT001150 | 1.11 | Protein ratios | Myeloid | 14 | 2 | 8 | 23 | |
| 1422 | TBCB levels | PROLV001999 | 1.10 | Protein levels | Platelet | 7 | 6 | 10 | 17 | |
| 1423 | SGSH levels | PROLV001850 | 1.10 | Protein levels | Myeloid | 70 | 3 | 11 | 22 | |
| 1424 | FIS1 levels | PROLV000806 | 1.10 | Protein levels | Myeloid | 54 | 3 | 8 | 20 | |
| 1425 | CIRBP levels | PROLV000437 | 1.09 | Protein levels | Myeloid | 8 | 2 | 6 | 15 | |
| 1426 | IFNAR1 levels | PROLV001018 | 1.09 | Protein levels | Myeloid | 52 | 4 | 11 | 23 | |
| 1427 | ACRBP levels | PROLV000016 | 1.09 | Protein levels | Lymphocyte | 3 | 2 | 7 | 20 | |
| 1428 | ILKAP levels | PROLV001082 | 1.09 | Protein levels | Vascular | 6 | 0 | 3 | 17 | |
| 1429 | VASH1 levels | PROLV002150 | 1.09 | Protein levels | Myeloid | 18 | 2 | 6 | 15 | |
| 1430 | ECG morphology, adjusted | ECGRM000001 | 1.09 | Electrocardiogram | Muscle / cardiac | 426 | 2 | 3 | 9 | |
| 1431 | CRIM1 levels | PROLV000522 | 1.09 | Protein levels | Vascular | 58 | 2 | 9 | 16 | |
| 1432 | LAP3 levels | PROLV001183 | 1.09 | Protein levels | Vascular | 8 | 2 | 6 | 12 | |
| 1433 | GSTA3 levels | PROLV000940 | 1.08 | Protein levels | Hepatocyte | 38 | 3 | 12 | 25 | |
| 1434 | CDK8_CCNC levels | PROLV000381 | 1.08 | Protein levels | Hepatocyte | 0 | 2 | 8 | 12 | |
| 1435 | SBSN levels | PROLV001777 | 1.08 | Protein levels | Hepatocyte | 28 | 2 | 9 | 18 | |
| 1436 | ACOT13 levels | PROLV000013 | 1.08 | Protein levels | Stromal / connective | 16 | 3 | 5 | 13 | |
| 1437 | TBL1X levels | PROLV002001 | 1.08 | Protein levels | Myeloid | 45 | 4 | 6 | 16 | |
| 1438 | AMBP/EFEMP1 ratio | PRORT000085 | 1.08 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 11 | |
| 1439 | Phosphatidylcholines | LIPID000058 | 1.08 | Lipids | Hepatocyte | 408 | 1 | 3 | 17 | |
| 1440 | CNTNAP2/DPP10 ratio | PRORT000689 | 1.08 | Protein ratios | Vascular | 0 | 1 | 4 | 9 | |
| 1441 | CD69/PLXNB3 ratio | PRORT000495 | 1.08 | Protein ratios | Myeloid | 0 | 3 | 8 | 16 | |
| 1442 | DPP4 levels | PROLV000646 | 1.08 | Protein levels | Myeloid | 44 | 3 | 12 | 22 | |
| 1443 | RHOC/TBCB ratio | PRORT001740 | 1.08 | Protein ratios | Myeloid | 0 | 4 | 11 | 21 | |
| 1444 | HTRA2 levels | PROLV001000 | 1.08 | Protein levels | Stromal / connective | 9 | 3 | 7 | 14 | |
| 1445 | Spondylosis | MSKEL000081 | 1.08 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 1446 | EIF4EBP1 levels | PROLV000697 | 1.08 | Protein levels | Muscle / cardiac | 5 | 3 | 9 | 20 | |
| 1447 | PDIA4 levels | PROLV001527 | 1.08 | Protein levels | Stromal / connective | 5 | 2 | 5 | 12 | |
| 1448 | CD300LG/CD93 ratio | PRORT000433 | 1.07 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 1449 | CDHR2/MME ratio | PRORT000563 | 1.07 | Protein ratios | Hepatocyte | 52 | 1 | 8 | 7 | |
| 1450 | ATG4A levels | PROLV000159 | 1.07 | Protein levels | Vascular | 0 | 3 | 11 | 31 | |
| 1451 | DNAJB1/SIRT2 ratio | PRORT000929 | 1.07 | Protein ratios | Hepatocyte | 54 | 1 | 9 | 7 | |
| 1452 | CCL17/F2R ratio | PRORT000344 | 1.07 | Protein ratios | Myeloid | 16 | 4 | 12 | 35 | |
| 1453 | IGFBP3 levels | PROLV001030 | 1.07 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 1454 | LTBP2/MYOC ratio | PRORT001464 | 1.07 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 1455 | CA2/UBAC1 ratio | PRORT000279 | 1.07 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 10 | |
| 1456 | TRIAP1 levels | PROLV002105 | 1.06 | Protein levels | Myeloid | 13 | 4 | 9 | 19 | |
| 1457 | CXCL17 levels | PROLV000582 | 1.06 | Protein levels | Vascular | 72 | 1 | 8 | 16 | |
| 1458 | TNIP1 levels | PROLV002082 | 1.06 | Protein levels | Myeloid | 6 | 3 | 3 | 12 | |
| 1459 | SYT1 levels | PROLV001985 | 1.06 | Protein levels | Granulosa cell | 25 | 1 | 6 | 12 | |
| 1460 | CCL19 levels | PROLV000285 | 1.06 | Protein levels | Lymphocyte | 61 | 1 | 10 | 16 | |
| 1461 | FGF2 levels | PROLV000794 | 1.06 | Protein levels | Adipose | 20 | 2 | 4 | 16 | |
| 1462 | LATS1 levels | PROLV001186 | 1.06 | Protein levels | Myeloid | 4 | 3 | 6 | 16 | |
| 1463 | APOM/ERBB3 ratio | PRORT000118 | 1.06 | Protein ratios | Hepatocyte | 22 | 1 | 9 | 15 | |
| 1464 | CD38/RELT ratio | PRORT000440 | 1.06 | Protein ratios | Muscle / cardiac | 2 | 2 | 9 | 17 | |
| 1465 | CNTN5/ROBO2 ratio | PRORT000688 | 1.06 | Protein ratios | Myeloid | 1 | 4 | 12 | 19 | |
| 1466 | FAM3B/GPA33 ratio | PRORT001113 | 1.06 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 1467 | ARHGEF12 levels | PROLV000141 | 1.06 | Protein levels | Hepatocyte | 17 | 1 | 6 | 14 | |
| 1468 | DLG4 levels | PROLV000624 | 1.06 | Protein levels | Lymphocyte | 5 | 1 | 5 | 33 | |
| 1469 | CLEC1B/RWDD1 ratio | PRORT000648 | 1.05 | Protein ratios | Hepatocyte | 7 | 3 | 7 | 15 | |
| 1470 | USP8 levels | PROLV002146 | 1.05 | Protein levels | Platelet | 2 | 5 | 6 | 11 | |
| 1471 | PPBP levels | PROLV001604 | 1.05 | Protein levels | Neural / glial | 68 | 3 | 9 | 15 | |
| 1472 | CD84/SEMA4D ratio | PRORT000527 | 1.05 | Protein ratios | Myeloid | 13 | 2 | 5 | 11 | |
| 1473 | AP3B1 levels | PROLV000111 | 1.05 | Protein levels | Stromal / connective | 3 | 2 | 6 | 12 | |
| 1474 | NSFL1C levels | PROLV001437 | 1.05 | Protein levels | Vascular | 9 | 1 | 8 | 21 | |
| 1475 | Arm mass | BCOMP000014 | 1.05 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 1476 | VSIR levels | PROLV002172 | 1.05 | Protein levels | Myeloid | 41 | 3 | 7 | 11 | |
| 1477 | CDKN1A/FXN ratio | PRORT000568 | 1.05 | Protein ratios | Hepatocyte | 19 | 2 | 10 | 18 | |
| 1478 | SERPINI1 levels | PROLV001836 | 1.05 | Protein levels | Myeloid | 23 | 1 | 6 | 9 | |
| 1479 | MPI/TACC3 ratio | PRORT001556 | 1.05 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 6 | 5 | |
| 1480 | CXCL5 levels | PROLV000584 | 1.05 | Protein levels | Platelet | 0 | 1 | 4 | 10 | |
| 1481 | Arrhythmia | CARDI000018 | 1.04 | Cardiac | Muscle / cardiac | 192 | 2 | 4 | 9 | |
| 1482 | STAMBP levels | PROLV001957 | 1.04 | Protein levels | Vascular | 0 | 3 | 9 | 20 | |
| 1483 | SPP1 levels | PROLV001938 | 1.04 | Protein levels | Vascular | 68 | 4 | 9 | 23 | |
| 1484 | CHMP6 levels | PROLV000432 | 1.04 | Protein levels | Stromal / connective | 7 | 4 | 6 | 19 | |
| 1485 | DFFA/FOXO1 ratio | PRORT000887 | 1.04 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 22 | |
| 1486 | SLMAP levels | PROLV001891 | 1.04 | Protein levels | Myeloid | 11 | 2 | 5 | 12 | |
| 1487 | BACH1/CNST ratio | PRORT000192 | 1.04 | Protein ratios | Myeloid | 5 | 1 | 9 | 11 | |
| 1488 | EFNA1/PIK3IP1 ratio | PRORT000989 | 1.04 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 1489 | DTX3 levels | PROLV000660 | 1.04 | Protein levels | Renal epithelium | 2 | 0 | 3 | 9 | |
| 1490 | CD4/LILRB4 ratio | PRORT000441 | 1.04 | Protein ratios | Myeloid | 61 | 4 | 11 | 12 | |
| 1491 | RIDA levels | PROLV001733 | 1.04 | Protein levels | Hepatocyte | 51 | 3 | 17 | 29 | |
| 1492 | Epigenetic age acceleration | AGING000002 | 1.03 | Aging | Hematopoietic progenitor | 25 | 1 | 3 | 22 | |
| 1493 | ITGB1/NCAM1 ratio | PRORT001378 | 1.03 | Protein ratios | Hepatocyte | 41 | 4 | 10 | 22 | |
| 1494 | COX5B/GFER ratio | PRORT000716 | 1.03 | Protein ratios | Lymphocyte | 1 | 1 | 12 | 33 | |
| 1495 | Benign neoplasm, Ocular | MALIG000005 | 1.03 | Malignancy | Melanocyte | 14 | 4 | 8 | 29 | |
| 1496 | FYB1 levels | PROLV000842 | 1.03 | Protein levels | Myeloid | 34 | 2 | 6 | 17 | |
| 1497 | Cancer, Endometrium | MALIG000014 | 1.03 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 1498 | CTSF/SMPDL3A ratio | PRORT000802 | 1.03 | Protein ratios | Hepatocyte | 30 | 1 | 7 | 18 | |
| 1499 | Employment status | SOCIO000005 | 1.03 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 1500 | VTI1A levels | PROLV002178 | 1.02 | Protein levels | Myeloid | 10 | 2 | 9 | 20 | |
| 1501 | APOD levels | PROLV000123 | 1.02 | Protein levels | Myeloid | 62 | 2 | 10 | 15 | |
| 1502 | CERT/PRTFDC1 ratio | PRORT000606 | 1.02 | Protein ratios | Hepatocyte | 0 | 2 | 6 | 13 | |
| 1503 | DNAJC6 levels | PROLV000635 | 1.02 | Protein levels | Hematopoietic progenitor | 9 | 5 | 7 | 15 | |
| 1504 | ABO levels | PROLV000007 | 1.02 | Protein levels | Muscle / cardiac | 5 | 1 | 6 | 10 | |
| 1505 | PLCB2 levels | PROLV001575 | 1.02 | Protein levels | Platelet | 16 | 2 | 4 | 15 | |
| 1506 | PTGDS levels | PROLV001664 | 1.02 | Protein levels | Renal epithelium | 59 | 0 | 9 | 11 | |
| 1507 | SLPI levels | PROLV001892 | 1.02 | Protein levels | Cutaneous epithelium | 0 | 0 | 11 | 9 | |
| 1508 | CRNN levels | PROLV000528 | 1.01 | Protein levels | Cutaneous epithelium | 11 | 1 | 8 | 10 | |
| 1509 | EDAR/TNFSF12 ratio | PRORT000982 | 1.01 | Protein ratios | Hematopoietic progenitor | 34 | 5 | 9 | 21 | |
| 1510 | CLEC1B/NSFL1C ratio | PRORT000645 | 1.01 | Protein ratios | Myeloid | 9 | 3 | 8 | 16 | |
| 1511 | CFH levels | PROLV000413 | 1.01 | Protein levels | Stromal / connective | 20 | 4 | 12 | 18 | |
| 1512 | ACADSB levels | PROLV000009 | 1.01 | Protein levels | Neural / glial | 22 | 4 | 10 | 20 | |
| 1513 | DNAJB6 levels | PROLV000633 | 1.01 | Protein levels | Platelet | 2 | 5 | 11 | 13 | |
| 1514 | Leg mass | BCOMP000017 | 1.01 | Body composition | Neural / glial | 384 | 5 | 10 | 15 | |
| 1515 | KIFBP levels | PROLV001140 | 1.01 | Protein levels | Myeloid | 33 | 1 | 5 | 9 | |
| 1516 | CA4/PECAM1 ratio | PRORT000282 | 1.00 | Protein ratios | Myeloid | 37 | 3 | 11 | 20 | |
| 1517 | BIN2 levels | PROLV000197 | 1.00 | Protein levels | Vascular | 27 | 2 | 6 | 11 | |
| 1518 | IL1R2 levels | PROLV001061 | 1.00 | Protein levels | Hepatocyte | 116 | 3 | 9 | 15 | |
| 1519 | CAMSAP1 levels | PROLV000260 | 1.00 | Protein levels | Myeloid | 2 | 2 | 2 | 10 | |
| 1520 | CRADD levels | PROLV000516 | 1.00 | Protein levels | Myeloid | 7 | 4 | 9 | 23 | |
| 1521 | UXS1 levels | PROLV002147 | 1.00 | Protein levels | Myeloid | 16 | 2 | 8 | 9 | |
| 1522 | PRR15 levels | PROLV001641 | 1.00 | Protein levels | Epithelial | 0 | 2 | 6 | 9 | |
| 1523 | NECTIN2/SDC1 ratio | PRORT001578 | 1.00 | Protein ratios | Hepatocyte | 59 | 1 | 11 | 9 | |
| 1524 | Polyamine metabolites | METAB000059 | 0.99 | Metabolites | Hepatocyte | 1 | 1 | 9 | 17 | |
| 1525 | SIAE/SNAP29 ratio | PRORT001785 | 0.99 | Protein ratios | Hepatocyte | 34 | 3 | 13 | 21 | |
| 1526 | CCL2/CCL7 ratio | PRORT000350 | 0.99 | Protein ratios | Myeloid | 13 | 3 | 9 | 15 | |
| 1527 | PTPN1/WWP2 ratio | PRORT001718 | 0.99 | Protein ratios | Muscle / cardiac | 12 | 2 | 14 | 27 | |
| 1528 | KCNA10 levels | PROLV001130 | 0.99 | Protein levels | Stromal / connective | 0 | 1 | 1 | 8 | |
| 1529 | CST1 levels | PROLV000548 | 0.99 | Protein levels | Salivary epithelium | 31 | 0 | 12 | 11 | |
| 1530 | PNLIPRP2 levels | PROLV001593 | 0.99 | Protein levels | Granulosa cell | 13 | 1 | 5 | 13 | |
| 1531 | CRKL/SERPINB1 ratio | PRORT000767 | 0.99 | Protein ratios | Myeloid | 1 | 5 | 15 | 18 | |
| 1532 | Brain general volume | NIMAG000015 | 0.99 | Neuroimaging | Neural / glial | 5 | 2 | 6 | 15 | |
| 1533 | Glutathione metabolites | METAB000006 | 0.99 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 1534 | DAPK2 levels | PROLV000593 | 0.99 | Protein levels | Myeloid | 21 | 3 | 9 | 7 | |
| 1535 | Steroid metabolite | METAB000073 | 0.99 | Metabolites | Hepatocyte | 38 | 1 | 3 | 13 | |
| 1536 | VAMP8 levels | PROLV002149 | 0.98 | Protein levels | Myeloid | 16 | 3 | 12 | 19 | |
| 1537 | CGREF1/FAM3C ratio | PRORT000609 | 0.98 | Protein ratios | Hepatocyte | 2 | 0 | 4 | 8 | |
| 1538 | NECTIN4/TGFBR2 ratio | PRORT001584 | 0.98 | Protein ratios | Epithelial | 18 | 0 | 6 | 12 | |
| 1539 | Peak expiratory flow | RESPI000023 | 0.98 | Respiratory | Stromal / connective | 305 | 2 | 5 | 8 | |
| 1540 | CACNA2D3 levels | PROLV000250 | 0.98 | Protein levels | B / plasma cell | 0 | 3 | 7 | 19 | |
| 1541 | HGS levels | PROLV000967 | 0.98 | Protein levels | Stromal / connective | 0 | 3 | 11 | 17 | |
| 1542 | SNX18 levels | PROLV001912 | 0.98 | Protein levels | Hepatocyte | 0 | 1 | 8 | 17 | |
| 1543 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 0.98 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 1544 | Consultant specialty, anaesthetics | MISCL000015 | 0.98 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 1545 | Liver enzyme levels, ALT | HPBIL000013 | 0.98 | Hepatopancreatobiliary | Hepatocyte | 1,395 | 2 | 5 | 15 | |
| 1546 | SERPINB6 levels | PROLV001825 | 0.98 | Protein levels | Muscle / cardiac | 5 | 5 | 10 | 23 | |
| 1547 | SLC9A3R1 levels | PROLV001885 | 0.98 | Protein levels | Myeloid | 7 | 4 | 9 | 17 | |
| 1548 | ARHGAP45 levels | PROLV000138 | 0.98 | Protein levels | Vascular | 15 | 2 | 4 | 24 | |
| 1549 | ANXA4/LACTB2 ratio | PRORT000112 | 0.97 | Protein ratios | Myeloid | 0 | 3 | 7 | 11 | |
| 1550 | Nephritis and nephropathy | NEPHR000010 | 0.97 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 1551 | Branched-chain amino acids | METAB000019 | 0.97 | Metabolites | Hepatocyte | 32 | 3 | 9 | 16 | |
| 1552 | HPCAL1/PMVK ratio | PRORT001298 | 0.97 | Protein ratios | Myeloid | 1 | 3 | 11 | 25 | |
| 1553 | Diglycerides | LIPID000038 | 0.97 | Lipids | Hepatocyte | 32 | 1 | 5 | 16 | |
| 1554 | MZT1 levels | PROLV001367 | 0.97 | Protein levels | Vascular | 0 | 2 | 7 | 12 | |
| 1555 | AXIN1/MAVS ratio | PRORT000175 | 0.97 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 1556 | TOP2B levels | PROLV002088 | 0.97 | Protein levels | Myeloid | 3 | 3 | 11 | 25 | |
| 1557 | Congenital cardiovascular malformations | CARDI000031 | 0.96 | Cardiac | Vascular | 0 | 4 | 10 | 28 | |
| 1558 | Biliary cirrhosis | HPBIL000005 | 0.96 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 1559 | BMP4 levels | PROLV000203 | 0.96 | Protein levels | Granulosa cell | 46 | 2 | 8 | 26 | |
| 1560 | GIPC3 levels | PROLV000889 | 0.96 | Protein levels | Platelet | 7 | 3 | 4 | 7 | |
| 1561 | PDLIM7/PLA2G4A ratio | PRORT001654 | 0.96 | Protein ratios | Platelet | 8 | 4 | 5 | 18 | |
| 1562 | CCN2/DKK1 ratio | PRORT000362 | 0.96 | Protein ratios | Muscle / cardiac | 7 | 4 | 13 | 29 | |
| 1563 | CDHR5 levels | PROLV000380 | 0.96 | Protein levels | Hepatocyte | 114 | 1 | 5 | 9 | |
| 1564 | F7 levels | PROLV000748 | 0.96 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 1565 | CASP10 levels | PROLV000266 | 0.96 | Protein levels | Lymphocyte | 3 | 4 | 11 | 33 | |
| 1566 | PINLYP levels | PROLV001562 | 0.96 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 1567 | CNST levels | PROLV000474 | 0.95 | Protein levels | Myeloid | 23 | 1 | 6 | 13 | |
| 1568 | CRTAM/PDCD1 ratio | PRORT000773 | 0.95 | Protein ratios | Lymphocyte | 7 | 2 | 19 | 43 | |
| 1569 | PRUNE2 levels | PROLV001652 | 0.95 | Protein levels | Hepatocyte | 23 | 1 | 3 | 15 | |
| 1570 | Medication, heart failure | CARDI000044 | 0.95 | Cardiac | Hepatocyte | 0 | 3 | 6 | 20 | |
| 1571 | Tryptophan | METAB000030 | 0.95 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 1572 | Subcortical volume | NIMAG000026 | 0.95 | Neuroimaging | Neural / glial | 6 | 0 | 0 | 0 | |
| 1573 | OTUD7B levels | PROLV001478 | 0.95 | Protein levels | Muscle / cardiac | 2 | 4 | 6 | 14 | |
| 1574 | TMED8 levels | PROLV002045 | 0.94 | Protein levels | Stromal / connective | 8 | 1 | 3 | 8 | |
| 1575 | MMP10 levels | PROLV001322 | 0.94 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 1576 | Benign neoplasm, Melanocytic | MALIG000004 | 0.94 | Malignancy | Stromal / connective | 2 | 0 | 0 | 5 | |
| 1577 | Liver enzyme levels, AST | HPBIL000014 | 0.94 | Hepatopancreatobiliary | Hepatocyte | 1,947 | 3 | 13 | 18 | |
| 1578 | APOA levels | PROLV000116 | 0.94 | Protein levels | Hepatocyte | 1,456 | 3 | 9 | 17 | |
| 1579 | EHBP1 levels | PROLV000689 | 0.94 | Protein levels | Stromal / connective | 18 | 3 | 5 | 18 | |
| 1580 | CD58/ERBB3 ratio | PRORT000472 | 0.94 | Protein ratios | Hepatocyte | 55 | 1 | 5 | 12 | |
| 1581 | THBS4 levels | PROLV002027 | 0.93 | Protein levels | Hepatocyte | 69 | 2 | 8 | 18 | |
| 1582 | ANXA4 levels | PROLV000108 | 0.93 | Protein levels | Myeloid | 31 | 2 | 6 | 17 | |
| 1583 | Medication, ACE inhibitor | VASCU000028 | 0.93 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 1584 | CKB levels | PROLV000440 | 0.93 | Protein levels | Muscle / cardiac | 40 | 3 | 5 | 15 | |
| 1585 | ALCAM/ENPP2 ratio | PRORT000070 | 0.93 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 1586 | Methionine metabolites | METAB000010 | 0.93 | Metabolites | Granulosa cell | 1 | 2 | 7 | 19 | |
| 1587 | Facial ageing | DERMA000039 | 0.93 | Dermatologic | Melanocyte | 22 | 0 | 0 | 0 | |
| 1588 | CLEC3B levels | PROLV000449 | 0.93 | Protein levels | Vascular | 23 | 3 | 7 | 16 | |
| 1589 | PGLS levels | PROLV001545 | 0.93 | Protein levels | Neural / glial | 0 | 5 | 6 | 27 | |
| 1590 | LMNB2 levels | PROLV001218 | 0.93 | Protein levels | Myeloid | 6 | 1 | 14 | 18 | |
| 1591 | CASP8/DDX58 ratio | PRORT000321 | 0.93 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 1592 | Sputum production | RESPI000033 | 0.93 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 1593 | LYPD3 levels | PROLV001252 | 0.93 | Protein levels | Epithelial | 159 | 2 | 5 | 7 | |
| 1594 | DKK1 levels | PROLV000620 | 0.93 | Protein levels | Myeloid | 37 | 2 | 9 | 12 | |
| 1595 | GZMA/TNFRSF8 ratio | PRORT001262 | 0.93 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 1596 | Hippocampal volume | NIMAG000024 | 0.93 | Neuroimaging | Stromal / connective | 0 | 0 | 0 | 0 | |
| 1597 | Urinary albumin | NEPHR000020 | 0.92 | Nephrourologic | Vascular | 29 | 2 | 10 | 12 | |
| 1598 | CX3CL1/LAYN ratio | PRORT000809 | 0.92 | Protein ratios | Vascular | 12 | 2 | 9 | 12 | |
| 1599 | FUT8/RSPO1 ratio | PRORT001188 | 0.92 | Protein ratios | Lymphocyte | 9 | 2 | 11 | 28 | |
| 1600 | Insulin sensitivity | METBL000042 | 0.92 | Metabolic | Myeloid | 1 | 1 | 3 | 8 | |
| 1601 | CTSF/NAAA ratio | PRORT000801 | 0.92 | Protein ratios | Hepatocyte | 46 | 3 | 13 | 23 | |
| 1602 | Benign neoplasm, Skin | MALIG000007 | 0.92 | Malignancy | Melanocyte | 10 | 0 | 5 | 10 | |
| 1603 | JAM2/RGMB ratio | PRORT001396 | 0.92 | Protein ratios | Vascular | 2 | 2 | 6 | 11 | |
| 1604 | CNTN2 levels | PROLV000476 | 0.92 | Protein levels | Vascular | 46 | 4 | 13 | 25 | |
| 1605 | CALCOCO1 levels | PROLV000257 | 0.92 | Protein levels | Vascular | 7 | 1 | 2 | 13 | |
| 1606 | CDH3 levels | PROLV000375 | 0.92 | Protein levels | Renal epithelium | 40 | 0 | 5 | 5 | |
| 1607 | AHSA1 levels | PROLV000064 | 0.92 | Protein levels | Vascular | 1 | 0 | 2 | 16 | |
| 1608 | MYCT1 levels | PROLV001357 | 0.92 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 1609 | TTR levels | PROLV002120 | 0.92 | Protein levels | Hepatocyte | 83 | 2 | 9 | 13 | |
| 1610 | TIE1 levels | PROLV002033 | 0.92 | Protein levels | Granulosa cell | 77 | 3 | 9 | 20 | |
| 1611 | Medication, peripheral vascular disease | VASCU000039 | 0.91 | Vascular | Myeloid | 0 | 1 | 5 | 9 | |
| 1612 | BLMH levels | PROLV000199 | 0.91 | Protein levels | Myeloid | 63 | 2 | 7 | 14 | |
| 1613 | CDKN1A/NCK2 ratio | PRORT000570 | 0.91 | Protein ratios | Vascular | 14 | 2 | 9 | 17 | |
| 1614 | TGFBR2/TNFRSF19 ratio | PRORT001834 | 0.91 | Protein ratios | Neural / glial | 12 | 3 | 7 | 13 | |
| 1615 | FSHB levels | PROLV000828 | 0.91 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 1616 | FURIN levels | PROLV000835 | 0.91 | Protein levels | Myeloid | 29 | 3 | 8 | 13 | |
| 1617 | NMT1 levels | PROLV001412 | 0.91 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 1618 | CCL23 levels | PROLV000290 | 0.91 | Protein levels | Myeloid | 101 | 3 | 9 | 24 | |
| 1619 | RILP levels | PROLV001734 | 0.91 | Protein levels | Lymphocyte | 22 | 2 | 15 | 42 | |
| 1620 | PTPRK levels | PROLV001677 | 0.91 | Protein levels | Hepatocyte | 30 | 1 | 8 | 20 | |
| 1621 | JPT2 levels | PROLV001127 | 0.91 | Protein levels | Lymphocyte | 2 | 4 | 10 | 20 | |
| 1622 | Lysophosphatidylinositols | LIPID000056 | 0.91 | Lipids | Hepatocyte | 3 | 2 | 5 | 20 | |
| 1623 | DSG2 levels | PROLV000655 | 0.91 | Protein levels | Epithelial | 31 | 0 | 9 | 6 | |
| 1624 | BGN levels | PROLV000194 | 0.91 | Protein levels | Myeloid | 66 | 1 | 10 | 12 | |
| 1625 | CD46/THBD ratio | PRORT000460 | 0.90 | Protein ratios | Vascular | 20 | 2 | 8 | 18 | |
| 1626 | ECM1 levels | PROLV000672 | 0.90 | Protein levels | Muscle / cardiac | 18 | 4 | 13 | 49 | |
| 1627 | SCG3 levels | PROLV001785 | 0.90 | Protein levels | Vascular | 110 | 0 | 8 | 11 | |
| 1628 | PTPRB levels | PROLV001673 | 0.90 | Protein levels | Vascular | 89 | 3 | 11 | 17 | |
| 1629 | PPP1R12A/TXNDC5 ratio | PRORT001703 | 0.90 | Protein ratios | Hepatocyte | 10 | 3 | 10 | 31 | |
| 1630 | ARHGEF1 levels | PROLV000139 | 0.90 | Protein levels | Myeloid | 5 | 2 | 5 | 9 | |
| 1631 | Hypertriglyceridaemia | METBL000023 | 0.90 | Metabolic | Hepatocyte | 117 | 1 | 5 | 20 | |
| 1632 | ITGB1/TFPI ratio | PRORT001381 | 0.90 | Protein ratios | Hepatocyte | 52 | 1 | 14 | 13 | |
| 1633 | Iris and ciliary body disorder | OPHTH000005 | 0.90 | Ophthalmic | Hepatocyte | 43 | 0 | 3 | 8 | |
| 1634 | RGMA/RGMB ratio | PRORT001736 | 0.90 | Protein ratios | Muscle / cardiac | 14 | 1 | 5 | 12 | |
| 1635 | COLEC12/TNFRSF1A ratio | PRORT000708 | 0.90 | Protein ratios | Myeloid | 18 | 3 | 10 | 15 | |
| 1636 | MAD1L1 levels | PROLV001257 | 0.90 | Protein levels | Myeloid | 6 | 5 | 12 | 26 | |
| 1637 | CCL22 levels | PROLV000289 | 0.90 | Protein levels | Myeloid | 15 | 2 | 8 | 17 | |
| 1638 | TAB2 levels | PROLV001987 | 0.90 | Protein levels | Myeloid | 0 | 2 | 3 | 9 | |
| 1639 | GAL levels | PROLV000847 | 0.89 | Protein levels | Hepatocyte | 129 | 1 | 11 | 16 | |
| 1640 | CASP8 levels | PROLV000270 | 0.89 | Protein levels | Vascular | 5 | 5 | 11 | 33 | |
| 1641 | AKT1S1 levels | PROLV000074 | 0.89 | Protein levels | Myeloid | 0 | 4 | 10 | 19 | |
| 1642 | SH2B3/TBL1X ratio | PRORT001784 | 0.89 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 26 | |
| 1643 | EEF1D levels | PROLV000677 | 0.89 | Protein levels | Platelet | 14 | 4 | 5 | 16 | |
| 1644 | FGL1 levels | PROLV000803 | 0.89 | Protein levels | Hepatocyte | 58 | 3 | 12 | 23 | |
| 1645 | CANT1/ROR1 ratio | PRORT000309 | 0.89 | Protein ratios | Hepatocyte | 3 | 1 | 9 | 25 | |
| 1646 | Gut microbial abundance, Holdemania | GASTR000026 | 0.89 | Gastrointestinal | Hepatocyte | 0 | 3 | 13 | 24 | |
| 1647 | CEP170 levels | PROLV000400 | 0.89 | Protein levels | Myeloid | 1 | 1 | 5 | 11 | |
| 1648 | NTF4 levels | PROLV001443 | 0.89 | Protein levels | Muscle / cardiac | 0 | 2 | 8 | 11 | |
| 1649 | Glycine metabolites | METAB000007 | 0.88 | Metabolites | Hepatocyte | 13 | 1 | 2 | 12 | |
| 1650 | AXL/VCAM1 ratio | PRORT000183 | 0.88 | Protein ratios | Myeloid | 85 | 4 | 15 | 37 | |
| 1651 | Anal and rectal disorder | GASTR000001 | 0.88 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 1652 | IFNGR1/IL10RB ratio | PRORT001331 | 0.88 | Protein ratios | Neural / glial | 4 | 2 | 5 | 11 | |
| 1653 | Steatohepatitis, nonalcoholic | HPBIL000032 | 0.88 | Hepatopancreatobiliary | Renal epithelium | 0 | 0 | 5 | 7 | |
| 1654 | SMPD1/SMPDL3A ratio | PRORT001792 | 0.88 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 14 | |
| 1655 | UROD levels | PROLV002143 | 0.88 | Protein levels | Lymphocyte | 2 | 2 | 9 | 33 | |
| 1656 | IL12B levels | PROLV001045 | 0.88 | Protein levels | Myeloid | 205 | 3 | 7 | 10 | |
| 1657 | BIN2/PDLIM7 ratio | PRORT000233 | 0.88 | Protein ratios | Muscle / cardiac | 1 | 3 | 8 | 22 | |
| 1658 | Phosphate | METAB000048 | 0.88 | Metabolites | Hepatocyte | 604 | 1 | 7 | 10 | |
| 1659 | Choroid plexus volume | NIMAG000020 | 0.88 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 1660 | MAP2K6/MGMT ratio | PRORT001485 | 0.88 | Protein ratios | Epithelial | 0 | 0 | 11 | 12 | |
| 1661 | TAX1BP1 levels | PROLV001994 | 0.88 | Protein levels | Myeloid | 8 | 2 | 5 | 19 | |
| 1662 | LRP11 levels | PROLV001230 | 0.87 | Protein levels | Vascular | 22 | 0 | 8 | 22 | |
| 1663 | USO1 levels | PROLV002144 | 0.87 | Protein levels | Platelet | 10 | 4 | 7 | 19 | |
| 1664 | QDPR/THOP1 ratio | PRORT001725 | 0.87 | Protein ratios | Hepatocyte | 14 | 4 | 10 | 24 | |
| 1665 | EGLN1/PSIP1 ratio | PRORT001005 | 0.87 | Protein ratios | Myeloid | 0 | 0 | 3 | 8 | |
| 1666 | CD69/NFATC1 ratio | PRORT000493 | 0.87 | Protein ratios | Myeloid | 0 | 2 | 13 | 37 | |
| 1667 | MMP3 levels | PROLV001325 | 0.87 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 1668 | Anaemia of chronic kidney disease | HEMAT000003 | 0.87 | Hematologic | Hepatocyte | 4 | 3 | 7 | 14 | |
| 1669 | RAP1A levels | PROLV001704 | 0.87 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 1670 | CERT/MAX ratio | PRORT000605 | 0.87 | Protein ratios | Stromal / connective | 0 | 4 | 12 | 23 | |
| 1671 | PRR4 levels | PROLV001642 | 0.87 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 1672 | PLAT levels | PROLV001571 | 0.86 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 1673 | CC2D1A levels | PROLV000273 | 0.86 | Protein levels | Vascular | 0 | 4 | 8 | 27 | |
| 1674 | LRRC25 levels | PROLV001232 | 0.86 | Protein levels | Myeloid | 135 | 2 | 9 | 10 | |
| 1675 | SDC4/SMAD1 ratio | PRORT001768 | 0.86 | Protein ratios | Myeloid | 18 | 4 | 9 | 26 | |
| 1676 | FOLR2/MSR1 ratio | PRORT001169 | 0.86 | Protein ratios | Myeloid | 40 | 2 | 10 | 11 | |
| 1677 | CD4 levels | PROLV000339 | 0.86 | Protein levels | Myeloid | 82 | 2 | 7 | 15 | |
| 1678 | NCS1 levels | PROLV001385 | 0.86 | Protein levels | Myeloid | 105 | 3 | 8 | 14 | |
| 1679 | Cervical disorder | REPRO000001 | 0.85 | Reproductive | Stromal / connective | 8 | 2 | 9 | 19 | |
| 1680 | MAX levels | PROLV001280 | 0.85 | Protein levels | Myeloid | 32 | 3 | 7 | 11 | |
| 1681 | CYTL1 levels | PROLV000589 | 0.85 | Protein levels | Stromal / connective | 2 | 2 | 4 | 6 | |
| 1682 | FCER2/TNFRSF9 ratio | PRORT001122 | 0.85 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 1683 | ASPSCR1 levels | PROLV000154 | 0.85 | Protein levels | Vascular | 0 | 0 | 3 | 9 | |
| 1684 | Abdominal adiposity | BCOMP000003 | 0.85 | Body composition | Neural / glial | 18 | 2 | 6 | 21 | |
| 1685 | SF3B4 levels | PROLV001843 | 0.85 | Protein levels | Myeloid | 8 | 3 | 11 | 20 | |
| 1686 | STK4 levels | PROLV001965 | 0.85 | Protein levels | Myeloid | 9 | 3 | 10 | 17 | |
| 1687 | Alcoholic liver disease | HPBIL000033 | 0.85 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 1688 | EREG/MPIG6B ratio | PRORT001058 | 0.85 | Protein ratios | Myeloid | 15 | 3 | 10 | 15 | |
| 1689 | ROBO1 levels | PROLV001749 | 0.85 | Protein levels | Myeloid | 129 | 2 | 7 | 15 | |
| 1690 | Tyrosine metabolites | METAB000016 | 0.85 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 1691 | DBN1 levels | PROLV000598 | 0.85 | Protein levels | Myeloid | 0 | 3 | 5 | 9 | |
| 1692 | GDF2 levels | PROLV000870 | 0.85 | Protein levels | Hepatocyte | 160 | 1 | 7 | 15 | |
| 1693 | Skin pigmentation | DERMA000026 | 0.85 | Dermatologic | Melanocyte | 78 | 1 | 1 | 3 | |
| 1694 | SERPINE1 levels | PROLV001830 | 0.84 | Protein levels | Platelet | 104 | 3 | 11 | 14 | |
| 1695 | CD79B/FCRL1 ratio | PRORT000510 | 0.84 | Protein ratios | B / plasma cell | 29 | 3 | 11 | 23 | |
| 1696 | OPHN1 levels | PROLV001470 | 0.84 | Protein levels | Platelet | 12 | 0 | 4 | 6 | |
| 1697 | PDGFB levels | PROLV001523 | 0.84 | Protein levels | Myeloid | 60 | 3 | 12 | 14 | |
| 1698 | CHAD levels | PROLV000423 | 0.84 | Protein levels | Myeloid | 27 | 3 | 9 | 11 | |
| 1699 | Immune cell marker, CD4 T cell | HEMAT000022 | 0.84 | Hematologic | Myeloid | 0 | 0 | 0 | 0 | |
| 1700 | MYO9B levels | PROLV001362 | 0.84 | Protein levels | Myeloid | 14 | 1 | 7 | 10 | |
| 1701 | OXCT1 levels | PROLV001479 | 0.84 | Protein levels | Myeloid | 26 | 3 | 10 | 10 | |
| 1702 | CIAPIN1/VEGFC ratio | PRORT000619 | 0.84 | Protein ratios | Platelet | 3 | 2 | 9 | 30 | |
| 1703 | Migraine | NEURO000010 | 0.84 | Neurologic | Neural / glial | 16 | 0 | 1 | 5 | |
| 1704 | LBR/POLR2F ratio | PRORT001439 | 0.84 | Protein ratios | Lymphocyte | 5 | 4 | 8 | 36 | |
| 1705 | CFI levels | PROLV000418 | 0.84 | Protein levels | Myeloid | 44 | 4 | 7 | 13 | |
| 1706 | ITGA5 levels | PROLV001106 | 0.83 | Protein levels | Myeloid | 158 | 3 | 6 | 10 | |
| 1707 | PSMG3 levels | PROLV001660 | 0.83 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 1708 | TACSTD2 levels | PROLV001989 | 0.83 | Protein levels | Neural / glial | 29 | 1 | 3 | 8 | |
| 1709 | COLEC12 levels | PROLV000494 | 0.83 | Protein levels | Stromal / connective | 9 | 1 | 4 | 6 | |
| 1710 | Heart failure | CARDI000007 | 0.83 | Cardiac | Muscle / cardiac | 37 | 2 | 3 | 10 | |
| 1711 | CD69/F2R ratio | PRORT000492 | 0.83 | Protein ratios | Myeloid | 13 | 4 | 12 | 24 | |
| 1712 | DRG2 levels | PROLV000652 | 0.83 | Protein levels | Lymphocyte | 1 | 3 | 7 | 30 | |
| 1713 | MANSC1 levels | PROLV001263 | 0.82 | Protein levels | Hepatocyte | 146 | 1 | 7 | 12 | |
| 1714 | Pregnancy complication, obstructed labour | REPRO000031 | 0.82 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 1715 | Family history, hypertension | VASCU000022 | 0.82 | Vascular | Hematopoietic progenitor | 2 | 0 | 1 | 5 | |
| 1716 | Heart failure, congestive | CARDI000004 | 0.82 | Cardiac | Muscle / cardiac | 6 | 2 | 5 | 14 | |
| 1717 | SHBG levels | PROLV001855 | 0.82 | Protein levels | Hepatocyte | 964 | 2 | 5 | 14 | |
| 1718 | Stimulant use disorder | PSYCH000048 | 0.82 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 1719 | ARHGEF5 levels | PROLV000142 | 0.82 | Protein levels | Lymphocyte | 8 | 0 | 3 | 13 | |
| 1720 | CXCL17/LAMP3 ratio | PRORT000823 | 0.82 | Protein ratios | Myeloid | 6 | 3 | 15 | 38 | |
| 1721 | SEC31A levels | PROLV001801 | 0.82 | Protein levels | Stromal / connective | 9 | 2 | 6 | 23 | |
| 1722 | CRKL levels | PROLV000526 | 0.82 | Protein levels | Platelet | 7 | 5 | 8 | 18 | |
| 1723 | LAT/PLXNA4 ratio | PRORT001425 | 0.82 | Protein ratios | Myeloid | 18 | 3 | 12 | 26 | |
| 1724 | RELT levels | PROLV001722 | 0.82 | Protein levels | Vascular | 6 | 0 | 5 | 8 | |
| 1725 | FBLN2 levels | PROLV000772 | 0.82 | Protein levels | Myeloid | 43 | 2 | 5 | 8 | |
| 1726 | IGDCC4 levels | PROLV001024 | 0.81 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 1727 | APOE levels | PROLV000124 | 0.81 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 1728 | PLXNA4/SRPK2 ratio | PRORT001686 | 0.81 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 1729 | Fat-free mass | BCOMP000008 | 0.81 | Body composition | Stromal / connective | 273 | 6 | 9 | 12 | |
| 1730 | Parental longevity | AGING000003 | 0.81 | Aging | Neural / glial | 8 | 1 | 2 | 16 | |
| 1731 | CD46/NECTIN2 ratio | PRORT000456 | 0.81 | Protein ratios | Vascular | 26 | 3 | 7 | 16 | |
| 1732 | FCN2 levels | PROLV000782 | 0.81 | Protein levels | Myeloid | 70 | 3 | 9 | 14 | |
| 1733 | MVK levels | PROLV001354 | 0.81 | Protein levels | Stromal / connective | 0 | 5 | 9 | 38 | |
| 1734 | KRT18 levels | PROLV001165 | 0.81 | Protein levels | Hepatocyte | 62 | 1 | 9 | 29 | |
| 1735 | AMIGO2 levels | PROLV000086 | 0.81 | Protein levels | Vascular | 39 | 1 | 6 | 15 | |
| 1736 | ADGRG2 levels | PROLV000047 | 0.81 | Protein levels | Myeloid | 24 | 2 | 8 | 15 | |
| 1737 | PGD levels | PROLV001543 | 0.80 | Protein levels | Myeloid | 9 | 4 | 14 | 19 | |
| 1738 | SERPINE1/USP8 ratio | PRORT001779 | 0.80 | Protein ratios | Lymphocyte | 0 | 4 | 16 | 40 | |
| 1739 | Conjunctivitis | OPHTH000002 | 0.80 | Ophthalmic | Lymphocyte | 26 | 3 | 10 | 30 | |
| 1740 | Medication, vasodilators | VASCU000041 | 0.80 | Vascular | Vascular | 3 | 2 | 5 | 5 | |
| 1741 | FOLR1 levels | PROLV000822 | 0.80 | Protein levels | Renal epithelium | 21 | 0 | 6 | 4 | |
| 1742 | BLOC1S3 levels | PROLV000201 | 0.80 | Protein levels | Myeloid | 19 | 2 | 2 | 6 | |
| 1743 | CRELD2 levels | PROLV000519 | 0.80 | Protein levels | Stromal / connective | 72 | 2 | 6 | 8 | |
| 1744 | Urinary retention | NEPHR000015 | 0.80 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 1745 | MGLL/PDLIM7 ratio | PRORT001528 | 0.80 | Protein ratios | Hepatocyte | 10 | 2 | 8 | 13 | |
| 1746 | DNAJB1/PPME1 ratio | PRORT000928 | 0.80 | Protein ratios | Hepatocyte | 31 | 3 | 13 | 18 | |
| 1747 | APOBR levels | PROLV000121 | 0.80 | Protein levels | Myeloid | 25 | 2 | 9 | 17 | |
| 1748 | ENO2/FXYD5 ratio | PRORT001022 | 0.79 | Protein ratios | Myeloid | 4 | 5 | 13 | 27 | |
| 1749 | Fatty acids, polyunsaturated | LIPID000026 | 0.79 | Lipids | Hepatocyte | 953 | 2 | 7 | 12 | |
| 1750 | CD244/GP1BA ratio | PRORT000409 | 0.79 | Protein ratios | Hematopoietic progenitor | 5 | 2 | 12 | 34 | |
| 1751 | DUSP3 levels | PROLV000663 | 0.79 | Protein levels | Myeloid | 6 | 1 | 7 | 11 | |
| 1752 | NUDT2 levels | PROLV001454 | 0.79 | Protein levels | Myeloid | 0 | 2 | 7 | 10 | |
| 1753 | Cancer, Urinary tract | MALIG000033 | 0.79 | Malignancy | Lymphocyte | 4 | 1 | 13 | 11 | |
| 1754 | Skin sebum | DERMA000036 | 0.79 | Dermatologic | Stromal / connective | 0 | 2 | 6 | 12 | |
| 1755 | FIS1/HSPA1A ratio | PRORT001149 | 0.79 | Protein ratios | Hepatocyte | 34 | 3 | 9 | 20 | |
| 1756 | MAP2K1 levels | PROLV001266 | 0.79 | Protein levels | Lymphocyte | 23 | 3 | 11 | 34 | |
| 1757 | PDCD5 levels | PROLV001517 | 0.79 | Protein levels | Lymphocyte | 4 | 3 | 14 | 25 | |
| 1758 | ARHGEF10 levels | PROLV000140 | 0.79 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 1759 | TCTN3 levels | PROLV002005 | 0.79 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 1760 | CNPY4/STAT5B ratio | PRORT000681 | 0.79 | Protein ratios | Hepatocyte | 2 | 3 | 12 | 17 | |
| 1761 | HSPB6 levels | PROLV000998 | 0.79 | Protein levels | Muscle / cardiac | 7 | 4 | 10 | 26 | |
| 1762 | BPIFB2 levels | PROLV000211 | 0.79 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 1763 | SH2B3 levels | PROLV001851 | 0.79 | Protein levels | Myeloid | 29 | 2 | 9 | 12 | |
| 1764 | CNTN1/EGFR ratio | PRORT000685 | 0.78 | Protein ratios | Hepatocyte | 69 | 2 | 10 | 12 | |
| 1765 | CCL13 levels | PROLV000279 | 0.78 | Protein levels | Myeloid | 139 | 1 | 8 | 13 | |
| 1766 | Occupational respiratory symptoms | RESPI000030 | 0.78 | Respiratory | Neural / glial | 0 | 1 | 4 | 11 | |
| 1767 | ATP5IF1/FIS1 ratio | PRORT000156 | 0.78 | Protein ratios | Myeloid | 28 | 3 | 11 | 12 | |
| 1768 | HPSE levels | PROLV000986 | 0.78 | Protein levels | Lymphocyte | 29 | 3 | 8 | 20 | |
| 1769 | VGF levels | PROLV002161 | 0.78 | Protein levels | Hepatocyte | 30 | 1 | 5 | 9 | |
| 1770 | BIRC2 levels | PROLV000198 | 0.78 | Protein levels | Stromal / connective | 1 | 3 | 7 | 14 | |
| 1771 | PMM2 levels | PROLV001589 | 0.78 | Protein levels | Stromal / connective | 2 | 2 | 6 | 12 | |
| 1772 | MANF/PDGFB ratio | PRORT001477 | 0.78 | Protein ratios | Myeloid | 3 | 4 | 8 | 16 | |
| 1773 | Bilirubin | HPBIL000017 | 0.78 | Hepatopancreatobiliary | Hepatocyte | 448 | 2 | 7 | 17 | |
| 1774 | NECTIN2/SPON2 ratio | PRORT001579 | 0.78 | Protein ratios | Hepatocyte | 17 | 1 | 5 | 10 | |
| 1775 | NUCB2 levels | PROLV001451 | 0.78 | Protein levels | Muscle / cardiac | 11 | 4 | 6 | 19 | |
| 1776 | VAV3 levels | PROLV002154 | 0.78 | Protein levels | Myeloid | 23 | 4 | 5 | 11 | |
| 1777 | Liver fat | HPBIL000023 | 0.77 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 1778 | PEAR1/SNAP23 ratio | PRORT001659 | 0.77 | Protein ratios | Neural / glial | 1 | 2 | 9 | 26 | |
| 1779 | TNFRSF21 levels | PROLV002070 | 0.77 | Protein levels | Renal epithelium | 63 | 0 | 9 | 14 | |
| 1780 | Suicidal behaviour | PSYCH000037 | 0.77 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 1781 | NRSN1 levels | PROLV001436 | 0.77 | Protein levels | Lymphocyte | 0 | 2 | 14 | 32 | |
| 1782 | IPCEF1/TBCC ratio | PRORT001365 | 0.77 | Protein ratios | B / plasma cell | 1 | 1 | 11 | 17 | |
| 1783 | EGF/MANF ratio | PRORT000995 | 0.77 | Protein ratios | Myeloid | 5 | 1 | 7 | 13 | |
| 1784 | CD58/LTBR ratio | PRORT000475 | 0.77 | Protein ratios | Epithelial | 25 | 0 | 6 | 14 | |
| 1785 | MSR1/TNFRSF21 ratio | PRORT001560 | 0.77 | Protein ratios | Myeloid | 29 | 3 | 12 | 12 | |
| 1786 | MILR1 levels | PROLV001314 | 0.77 | Protein levels | Hepatocyte | 64 | 2 | 5 | 19 | |
| 1787 | LRPAP1 levels | PROLV001231 | 0.77 | Protein levels | Vascular | 92 | 3 | 8 | 20 | |
| 1788 | TXLNA levels | PROLV002122 | 0.76 | Protein levels | Platelet | 3 | 1 | 5 | 17 | |
| 1789 | GP6 levels | PROLV000917 | 0.76 | Protein levels | Myeloid | 21 | 2 | 6 | 18 | |
| 1790 | RAB2B levels | PROLV001698 | 0.76 | Protein levels | Stromal / connective | 1 | 3 | 4 | 9 | |
| 1791 | KLK8/LY6D ratio | PRORT001411 | 0.76 | Protein ratios | Cutaneous epithelium | 4 | 0 | 6 | 2 | |
| 1792 | CA13 levels | PROLV000242 | 0.76 | Protein levels | Platelet | 19 | 3 | 4 | 16 | |
| 1793 | FCN1 levels | PROLV000781 | 0.76 | Protein levels | Myeloid | 95 | 2 | 8 | 18 | |
| 1794 | CC2D1A/WWP2 ratio | PRORT000331 | 0.76 | Protein ratios | Stromal / connective | 0 | 0 | 4 | 5 | |
| 1795 | WFIKKN1 levels | PROLV002191 | 0.76 | Protein levels | Vascular | 125 | 2 | 7 | 15 | |
| 1796 | Cancer, Bladder | MALIG000009 | 0.76 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 1797 | TCN1 levels | PROLV002003 | 0.76 | Protein levels | Myeloid | 74 | 3 | 9 | 13 | |
| 1798 | FCRL2/SEMA7A ratio | PRORT001131 | 0.76 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 1799 | BST1 levels | PROLV000215 | 0.75 | Protein levels | Myeloid | 31 | 1 | 5 | 7 | |
| 1800 | CTSH levels | PROLV000565 | 0.75 | Protein levels | Hepatocyte | 29 | 2 | 8 | 17 | |
| 1801 | NFKBIE levels | PROLV001399 | 0.75 | Protein levels | Myeloid | 3 | 2 | 8 | 14 | |
| 1802 | HYAL1 levels | PROLV001001 | 0.75 | Protein levels | Vascular | 33 | 3 | 10 | 14 | |
| 1803 | PPCDC/RWDD1 ratio | PRORT001699 | 0.75 | Protein ratios | Myeloid | 9 | 4 | 8 | 20 | |
| 1804 | GRAP2/TYMP ratio | PRORT001247 | 0.75 | Protein ratios | Hepatocyte | 7 | 4 | 11 | 25 | |
| 1805 | FSTL3/LTBR ratio | PRORT001181 | 0.75 | Protein ratios | Vascular | 1 | 2 | 8 | 11 | |
| 1806 | Frailty, multimorbidity | METBL000012 | 0.75 | Metabolic | Vascular | 188 | 3 | 10 | 10 | |
| 1807 | TRIM24 levels | PROLV002107 | 0.75 | Protein levels | Muscle / cardiac | 1 | 3 | 6 | 15 | |
| 1808 | CELA3A/PLA2G1B ratio | PRORT000598 | 0.74 | Protein ratios | Vascular | 34 | 1 | 5 | 11 | |
| 1809 | CXCL6/DFFA ratio | PRORT000834 | 0.74 | Protein ratios | Hepatocyte | 2 | 2 | 9 | 18 | |
| 1810 | CSPG4 levels | PROLV000546 | 0.74 | Protein levels | Myeloid | 93 | 3 | 12 | 18 | |
| 1811 | ACOX1/VSIR ratio | PRORT000013 | 0.74 | Protein ratios | Myeloid | 16 | 1 | 6 | 12 | |
| 1812 | EHD3 levels | PROLV000690 | 0.74 | Protein levels | Stromal / connective | 14 | 5 | 8 | 17 | |
| 1813 | Gastrointestinal endoscopy | GASTR000042 | 0.74 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 1814 | EIF4G1/PLA2G4A ratio | PRORT001013 | 0.74 | Protein ratios | Vascular | 11 | 2 | 10 | 16 | |
| 1815 | INPPL1 levels | PROLV001091 | 0.74 | Protein levels | Vascular | 17 | 3 | 10 | 24 | |
| 1816 | Medication, analgesic | MISCL000034 | 0.73 | Miscellaneous | Neural / glial | 28 | 4 | 8 | 28 | |
| 1817 | Pain, generic | MSKEL000035 | 0.73 | Musculoskeletal | Neural / glial | 4 | 4 | 17 | 25 | |
| 1818 | TFPI levels | PROLV002015 | 0.73 | Protein levels | Hepatocyte | 121 | 2 | 8 | 15 | |
| 1819 | Arterial disease | VASCU000023 | 0.73 | Vascular | Vascular | 66 | 3 | 10 | 16 | |
| 1820 | CCN1 levels | PROLV000301 | 0.73 | Protein levels | Hepatocyte | 100 | 2 | 10 | 18 | |
| 1821 | CA13/TIA1 ratio | PRORT000272 | 0.73 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 25 | |
| 1822 | LRRN1 levels | PROLV001236 | 0.73 | Protein levels | Muscle / cardiac | 81 | 3 | 8 | 25 | |
| 1823 | APOH levels | PROLV000126 | 0.73 | Protein levels | Hepatocyte | 2 | 2 | 10 | 17 | |
| 1824 | TRAF2/WWP2 ratio | PRORT001857 | 0.73 | Protein ratios | Lymphocyte | 1 | 3 | 18 | 51 | |
| 1825 | CD46 levels | PROLV000342 | 0.73 | Protein levels | Vascular | 58 | 2 | 8 | 12 | |
| 1826 | Gut microbial abundance, Massiliomicrobiota | GASTR000028 | 0.73 | Gastrointestinal | Renal epithelium | 0 | 0 | 8 | 8 | |
| 1827 | SERPINE1/VASH1 ratio | PRORT001780 | 0.73 | Protein ratios | Myeloid | 10 | 3 | 11 | 23 | |
| 1828 | CANT1/HSPB1 ratio | PRORT000307 | 0.73 | Protein ratios | Myeloid | 10 | 4 | 9 | 28 | |
| 1829 | Hepatomegaly | HPBIL000022 | 0.72 | Hepatopancreatobiliary | Hepatocyte | 12 | 3 | 9 | 19 | |
| 1830 | SDC4/WWP2 ratio | PRORT001769 | 0.72 | Protein ratios | Myeloid | 11 | 3 | 10 | 19 | |
| 1831 | PEAR1/PECAM1 ratio | PRORT001657 | 0.72 | Protein ratios | Myeloid | 24 | 3 | 15 | 24 | |
| 1832 | TJAP1 levels | PROLV002043 | 0.72 | Protein levels | Stromal / connective | 1 | 2 | 5 | 14 | |
| 1833 | PPME1 levels | PROLV001612 | 0.72 | Protein levels | Vascular | 9 | 4 | 12 | 31 | |
| 1834 | NT5E levels | PROLV001441 | 0.72 | Protein levels | Hepatocyte | 96 | 1 | 10 | 9 | |
| 1835 | EIF4G1/MAVS ratio | PRORT001011 | 0.72 | Protein ratios | Myeloid | 22 | 3 | 9 | 16 | |
| 1836 | KIFBP/TBC1D23 ratio | PRORT001405 | 0.72 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 24 | |
| 1837 | FABP9 levels | PROLV000757 | 0.72 | Protein levels | Cutaneous epithelium | 43 | 0 | 4 | 5 | |
| 1838 | B4GALT1/SMOC2 ratio | PRORT000189 | 0.71 | Protein ratios | Myeloid | 7 | 2 | 6 | 18 | |
| 1839 | QDPR levels | PROLV001692 | 0.71 | Protein levels | Lymphocyte | 0 | 5 | 14 | 33 | |
| 1840 | MNX1 levels | PROLV001330 | 0.71 | Protein levels | Neural / glial | 0 | 2 | 6 | 13 | |
| 1841 | ADH4/KRT18 ratio | PRORT000040 | 0.71 | Protein ratios | Hepatocyte | 12 | 1 | 11 | 17 | |
| 1842 | CDH1/CST3 ratio | PRORT000546 | 0.71 | Protein ratios | Hepatocyte | 11 | 1 | 7 | 16 | |
| 1843 | TNFRSF4/TNFRSF8 ratio | PRORT001853 | 0.71 | Protein ratios | Vascular | 2 | 2 | 6 | 10 | |
| 1844 | LBR levels | PROLV001189 | 0.71 | Protein levels | Lymphocyte | 6 | 5 | 12 | 47 | |
| 1845 | ITGB5/S100A4 ratio | PRORT001392 | 0.71 | Protein ratios | Myeloid | 11 | 3 | 8 | 10 | |
| 1846 | ENDOU levels | PROLV000703 | 0.71 | Protein levels | Cutaneous epithelium | 77 | 2 | 12 | 12 | |
| 1847 | DNAJA2 levels | PROLV000629 | 0.71 | Protein levels | Vascular | 25 | 3 | 5 | 16 | |
| 1848 | KDR levels | PROLV001133 | 0.71 | Protein levels | Granulosa cell | 62 | 1 | 3 | 5 | |
| 1849 | F7/PROC ratio | PRORT001088 | 0.71 | Protein ratios | Hepatocyte | 35 | 1 | 10 | 12 | |
| 1850 | DIABLO levels | PROLV000618 | 0.71 | Protein levels | Platelet | 35 | 1 | 5 | 12 | |
| 1851 | CD48/FCRL6 ratio | PRORT000464 | 0.70 | Protein ratios | Lymphocyte | 25 | 2 | 12 | 34 | |
| 1852 | VEGFA levels | PROLV002157 | 0.70 | Protein levels | Muscle / cardiac | 30 | 1 | 5 | 14 | |
| 1853 | SCGN levels | PROLV001789 | 0.70 | Protein levels | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 1854 | CNTNAP4 levels | PROLV000481 | 0.70 | Protein levels | Lymphocyte | 38 | 0 | 7 | 16 | |
| 1855 | DOK2/SNX9 ratio | PRORT000943 | 0.70 | Protein ratios | Hepatocyte | 22 | 3 | 7 | 18 | |
| 1856 | PF4 levels | PROLV001538 | 0.70 | Protein levels | Myeloid | 34 | 4 | 9 | 18 | |
| 1857 | ADAMTSL5 levels | PROLV000038 | 0.70 | Protein levels | Muscle / cardiac | 9 | 4 | 6 | 14 | |
| 1858 | INPP1 levels | PROLV001089 | 0.70 | Protein levels | Stromal / connective | 0 | 2 | 6 | 19 | |
| 1859 | Phospholipids, VLDL | LIPID000051 | 0.70 | Lipids | Hepatocyte | 1,563 | 2 | 8 | 19 | |
| 1860 | Ataxia | NEURO000013 | 0.70 | Neurologic | Neural / glial | 0 | 3 | 9 | 22 | |
| 1861 | IL18R1 levels | PROLV001056 | 0.70 | Protein levels | Hepatocyte | 88 | 1 | 5 | 7 | |
| 1862 | Phosphatidylethanolamines | LIPID000059 | 0.70 | Lipids | Hepatocyte | 24 | 0 | 1 | 3 | |
| 1863 | DECR1 levels | PROLV000612 | 0.70 | Protein levels | Myeloid | 4 | 1 | 6 | 8 | |
| 1864 | ATXN10/CASP10 ratio | PRORT000161 | 0.70 | Protein ratios | Granulosa cell | 1 | 4 | 9 | 24 | |
| 1865 | Cancer, Brain | MALIG000010 | 0.69 | Malignancy | Muscle / cardiac | 0 | 2 | 4 | 13 | |
| 1866 | Gastric ulcer | GASTR000048 | 0.69 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 1867 | ATP5IF1 levels | PROLV000161 | 0.69 | Protein levels | Myeloid | 43 | 2 | 5 | 14 | |
| 1868 | Body fat percentage | BCOMP000004 | 0.69 | Body composition | Neural / glial | 409 | 3 | 9 | 19 | |
| 1869 | Ceramides | LIPID000065 | 0.69 | Lipids | Hepatocyte | 6 | 1 | 3 | 15 | |
| 1870 | CCL7 levels | PROLV000299 | 0.69 | Protein levels | Myeloid | 29 | 3 | 9 | 16 | |
| 1871 | WARS levels | PROLV002183 | 0.68 | Protein levels | Lymphocyte | 52 | 3 | 12 | 28 | |
| 1872 | SSNA1 levels | PROLV001950 | 0.68 | Protein levels | Platelet | 5 | 7 | 14 | 25 | |
| 1873 | CDKN1A/TMSB10 ratio | PRORT000574 | 0.68 | Protein ratios | Hepatocyte | 31 | 2 | 13 | 28 | |
| 1874 | DBNL levels | PROLV000599 | 0.68 | Protein levels | Lymphocyte | 3 | 4 | 10 | 25 | |
| 1875 | NFATC1/TJAP1 ratio | PRORT001587 | 0.68 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 8 | |
| 1876 | CFHR5 levels | PROLV000417 | 0.68 | Protein levels | Hepatocyte | 18 | 3 | 9 | 16 | |
| 1877 | MOG/SEZ6L ratio | PRORT001553 | 0.68 | Protein ratios | Myeloid | 7 | 2 | 9 | 13 | |
| 1878 | NUBP1 levels | PROLV001450 | 0.68 | Protein levels | B / plasma cell | 26 | 1 | 8 | 16 | |
| 1879 | Drug hypersensitivity | IMMUN000006 | 0.68 | Immunologic | Lymphocyte | 23 | 4 | 14 | 32 | |
| 1880 | CC2D1A/TMSB10 ratio | PRORT000330 | 0.68 | Protein ratios | Myeloid | 4 | 3 | 11 | 27 | |
| 1881 | AXL/MCAM ratio | PRORT000181 | 0.68 | Protein ratios | Myeloid | 18 | 2 | 5 | 15 | |
| 1882 | Medication, antihypertensive | VASCU000031 | 0.68 | Vascular | Vascular | 332 | 2 | 4 | 9 | |
| 1883 | CRHBP levels | PROLV000521 | 0.68 | Protein levels | Myeloid | 30 | 2 | 7 | 9 | |
| 1884 | CCL25 levels | PROLV000292 | 0.68 | Protein levels | Vascular | 127 | 0 | 2 | 11 | |
| 1885 | NUCB2/TRIAP1 ratio | PRORT001607 | 0.68 | Protein ratios | Hepatocyte | 0 | 5 | 11 | 27 | |
| 1886 | NMI levels | PROLV001410 | 0.68 | Protein levels | Myeloid | 6 | 4 | 10 | 13 | |
| 1887 | CD83/TREM2 ratio | PRORT000519 | 0.68 | Protein ratios | Myeloid | 56 | 3 | 11 | 15 | |
| 1888 | CD27/TNFRSF9 ratio | PRORT000419 | 0.68 | Protein ratios | B / plasma cell | 20 | 5 | 15 | 40 | |
| 1889 | SMAD5 levels | PROLV001897 | 0.68 | Protein levels | Myeloid | 95 | 2 | 6 | 11 | |
| 1890 | VASP levels | PROLV002152 | 0.68 | Protein levels | Lymphocyte | 2 | 3 | 7 | 21 | |
| 1891 | Pre-eclampsia | VASCU000047 | 0.68 | Vascular | Myeloid | 7 | 2 | 3 | 7 | |
| 1892 | ENG/PEAR1 ratio | PRORT001019 | 0.68 | Protein ratios | Granulosa cell | 3 | 3 | 11 | 21 | |
| 1893 | PPP1R12A/SPARC ratio | PRORT001702 | 0.68 | Protein ratios | Myeloid | 1 | 2 | 11 | 18 | |
| 1894 | Placental weight | REPRO000026 | 0.67 | Reproductive | Hepatocyte | 59 | 3 | 8 | 17 | |
| 1895 | KYNU/SCLY ratio | PRORT001416 | 0.67 | Protein ratios | Hepatocyte | 7 | 4 | 16 | 39 | |
| 1896 | CKAP4 levels | PROLV000439 | 0.67 | Protein levels | Hepatocyte | 101 | 3 | 10 | 21 | |
| 1897 | Chronic obstructive pulmonary disease, COPD | RESPI000009 | 0.67 | Respiratory | Neural / glial | 75 | 1 | 2 | 6 | |
| 1898 | THY1 levels | PROLV002031 | 0.67 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 1899 | FGD3 levels | PROLV000792 | 0.67 | Protein levels | Platelet | 25 | 4 | 8 | 18 | |
| 1900 | LBP levels | PROLV001188 | 0.67 | Protein levels | Hepatocyte | 18 | 2 | 7 | 22 | |
| 1901 | IGFBP6 levels | PROLV001032 | 0.67 | Protein levels | Hepatocyte | 24 | 1 | 5 | 7 | |
| 1902 | CMC1 levels | PROLV000469 | 0.67 | Protein levels | Stromal / connective | 28 | 2 | 5 | 14 | |
| 1903 | CD40LG/TRAF2 ratio | PRORT000455 | 0.67 | Protein ratios | Lymphocyte | 4 | 2 | 13 | 45 | |
| 1904 | SPRY2 levels | PROLV001940 | 0.67 | Protein levels | Lymphocyte | 16 | 3 | 10 | 23 | |
| 1905 | CCL15/CCL23 ratio | PRORT000341 | 0.67 | Protein ratios | Myeloid | 7 | 1 | 6 | 27 | |
| 1906 | CDKN1A/PLA2G4A ratio | PRORT000571 | 0.67 | Protein ratios | Vascular | 14 | 4 | 12 | 23 | |
| 1907 | Histidine metabolites | METAB000008 | 0.67 | Metabolites | Granulosa cell | 3 | 0 | 3 | 9 | |
| 1908 | IL6ST/LEPR ratio | PRORT001353 | 0.67 | Protein ratios | Hepatocyte | 42 | 3 | 10 | 13 | |
| 1909 | PRKG1 levels | PROLV001633 | 0.67 | Protein levels | Stromal / connective | 10 | 4 | 7 | 15 | |
| 1910 | MAPK13 levels | PROLV001270 | 0.66 | Protein levels | Hepatocyte | 7 | 3 | 8 | 12 | |
| 1911 | SETMAR levels | PROLV001839 | 0.66 | Protein levels | Myeloid | 63 | 2 | 8 | 10 | |
| 1912 | TXNRD1 levels | PROLV002127 | 0.66 | Protein levels | Myeloid | 26 | 3 | 10 | 19 | |
| 1913 | PPM1F levels | PROLV001611 | 0.66 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 1914 | MAN1A2 levels | PROLV001260 | 0.66 | Protein levels | Myeloid | 160 | 3 | 12 | 14 | |
| 1915 | STIP1/TMSB10 ratio | PRORT001818 | 0.66 | Protein ratios | Muscle / cardiac | 13 | 3 | 8 | 22 | |
| 1916 | SEZ6L2 levels | PROLV001842 | 0.66 | Protein levels | Myeloid | 148 | 2 | 6 | 12 | |
| 1917 | MELTF levels | PROLV001295 | 0.66 | Protein levels | Myeloid | 23 | 3 | 9 | 11 | |
| 1918 | Cardiac imaging | CARDI000011 | 0.66 | Cardiac | Muscle / cardiac | 20 | 2 | 6 | 19 | |
| 1919 | Cholesterol, HDL | LIPID000003 | 0.66 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 1920 | GPLD1 levels | PROLV000926 | 0.66 | Protein levels | Lymphocyte | 0 | 1 | 4 | 8 | |
| 1921 | AIF1 levels | PROLV000068 | 0.66 | Protein levels | Myeloid | 36 | 3 | 9 | 13 | |
| 1922 | NT5C3A/PRDX5 ratio | PRORT001602 | 0.66 | Protein ratios | Myeloid | 0 | 2 | 8 | 14 | |
| 1923 | Immune cell marker, B cell | HEMAT000021 | 0.66 | Hematologic | Myeloid | 24 | 0 | 3 | 10 | |
| 1924 | CST6/GAL ratio | PRORT000791 | 0.66 | Protein ratios | Respiratory epithelium | 45 | 2 | 8 | 14 | |
| 1925 | Trihexosylceramides | LIPID000073 | 0.66 | Lipids | Granulosa cell | 7 | 2 | 5 | 4 | |
| 1926 | PLTP levels | PROLV001582 | 0.65 | Protein levels | Myeloid | 143 | 4 | 14 | 17 | |
| 1927 | RECK levels | PROLV001716 | 0.65 | Protein levels | Myeloid | 64 | 0 | 7 | 7 | |
| 1928 | CGREF1 levels | PROLV000421 | 0.65 | Protein levels | Hepatocyte | 11 | 0 | 6 | 9 | |
| 1929 | Perivascular space burden | NIMAG000011 | 0.65 | Neuroimaging | Muscle / cardiac | 3 | 2 | 5 | 7 | |
| 1930 | AGR3 levels | PROLV000056 | 0.65 | Protein levels | Myeloid | 11 | 1 | 7 | 10 | |
| 1931 | TARBP2/TDRKH ratio | PRORT001826 | 0.65 | Protein ratios | Granulosa cell | 0 | 3 | 8 | 16 | |
| 1932 | Cerebellar volume | NIMAG000019 | 0.65 | Neuroimaging | Myeloid | 12 | 0 | 0 | 1 | |
| 1933 | CDC26 levels | PROLV000366 | 0.65 | Protein levels | Vascular | 2 | 2 | 6 | 23 | |
| 1934 | MNDA/NCF2 ratio | PRORT001550 | 0.65 | Protein ratios | Myeloid | 13 | 2 | 5 | 6 | |
| 1935 | Dental caries | DENTA000004 | 0.65 | Dental | Stromal / connective | 2 | 1 | 4 | 7 | |
| 1936 | ASAH1 levels | PROLV000149 | 0.65 | Protein levels | Myeloid | 48 | 6 | 13 | 26 | |
| 1937 | BRAP levels | PROLV000212 | 0.65 | Protein levels | Vascular | 9 | 2 | 7 | 12 | |
| 1938 | Alpha-1-antitrypsin deficiency | RESPI000005 | 0.65 | Respiratory | Granulosa cell | 4 | 3 | 10 | 14 | |
| 1939 | RBKS levels | PROLV001709 | 0.65 | Protein levels | Hepatocyte | 23 | 1 | 7 | 17 | |
| 1940 | MICB or MICA levels | PROLV001312 | 0.65 | Protein levels | Lymphocyte | 148 | 2 | 12 | 35 | |
| 1941 | BACH1/NFATC1 ratio | PRORT000196 | 0.65 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 11 | |
| 1942 | SNAP23/TBL1X ratio | PRORT001794 | 0.65 | Protein ratios | Myeloid | 9 | 3 | 13 | 22 | |
| 1943 | ISM1 levels | PROLV001102 | 0.65 | Protein levels | Hepatocyte | 88 | 3 | 14 | 29 | |
| 1944 | Cancer, Ovary | MALIG000024 | 0.64 | Malignancy | Gastrointestinal epithelium | 23 | 0 | 7 | 13 | |
| 1945 | HSPA1A levels | PROLV000996 | 0.64 | Protein levels | Lymphocyte | 33 | 3 | 14 | 40 | |
| 1946 | SH3BP1 levels | PROLV001853 | 0.64 | Protein levels | Myeloid | 33 | 1 | 7 | 6 | |
| 1947 | SUSD2 levels | PROLV001979 | 0.64 | Protein levels | B / plasma cell | 15 | 3 | 8 | 14 | |
| 1948 | ZBTB16 levels | PROLV002209 | 0.64 | Protein levels | Muscle / cardiac | 43 | 3 | 6 | 15 | |
| 1949 | PPP3R1 levels | PROLV001620 | 0.64 | Protein levels | Myeloid | 20 | 2 | 10 | 18 | |
| 1950 | RTN4IP1 levels | PROLV001761 | 0.64 | Protein levels | Myeloid | 2 | 2 | 5 | 11 | |
| 1951 | CHRDL1 levels | PROLV000433 | 0.64 | Protein levels | B / plasma cell | 1 | 2 | 4 | 9 | |
| 1952 | Liver disorder | HPBIL000011 | 0.64 | Hepatopancreatobiliary | Hepatocyte | 78 | 1 | 3 | 11 | |
| 1953 | Surgical history | MISCL000031 | 0.64 | Miscellaneous | Hematopoietic progenitor | 22 | 1 | 1 | 6 | |
| 1954 | Triglycerides x psychiatric interaction | LIPID000040 | 0.64 | Lipids | Hepatocyte | 86 | 2 | 7 | 21 | |
| 1955 | GRPEL1 levels | PROLV000935 | 0.64 | Protein levels | Hepatocyte | 23 | 2 | 8 | 24 | |
| 1956 | ALDH1A1 levels | PROLV000079 | 0.64 | Protein levels | Hepatocyte | 16 | 2 | 9 | 22 | |
| 1957 | Sex-differentiated cardiometabolic traits | MISCL000002 | 0.64 | Miscellaneous | Hepatocyte | 733 | 1 | 9 | 15 | |
| 1958 | Dihydrosphingomyelins | LIPID000067 | 0.64 | Lipids | Epithelial | 0 | 0 | 6 | 10 | |
| 1959 | CWC15 levels | PROLV000572 | 0.64 | Protein levels | Lymphocyte | 7 | 2 | 12 | 34 | |
| 1960 | SPINK2 levels | PROLV001928 | 0.64 | Protein levels | Lymphocyte | 29 | 4 | 16 | 31 | |
| 1961 | TIMM10 levels | PROLV002036 | 0.64 | Protein levels | Stromal / connective | 21 | 2 | 6 | 11 | |
| 1962 | Glomerular disease | NEPHR000006 | 0.64 | Nephrourologic | Adipose | 5 | 2 | 3 | 9 | |
| 1963 | Shift work | SOCIO000008 | 0.64 | Socioeconomic | Granulosa cell | 0 | 1 | 4 | 18 | |
| 1964 | HGF/MMP8 ratio | PRORT001282 | 0.63 | Protein ratios | Hepatocyte | 3 | 3 | 11 | 19 | |
| 1965 | LILRA2 levels | PROLV001211 | 0.63 | Protein levels | Myeloid | 99 | 3 | 11 | 16 | |
| 1966 | TRIM58 levels | PROLV002111 | 0.63 | Protein levels | Vascular | 3 | 2 | 7 | 10 | |
| 1967 | Androgen metabolite | METAB000071 | 0.63 | Metabolites | Hepatocyte | 77 | 1 | 6 | 13 | |
| 1968 | ADAM12 levels | PROLV000025 | 0.63 | Protein levels | B / plasma cell | 2 | 2 | 6 | 12 | |
| 1969 | SLA2 levels | PROLV001874 | 0.63 | Protein levels | Stromal / connective | 21 | 4 | 5 | 9 | |
| 1970 | CA1 levels | PROLV000239 | 0.63 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 1971 | FLT1/TFPI2 ratio | PRORT001162 | 0.63 | Protein ratios | Myeloid | 3 | 5 | 11 | 21 | |
| 1972 | DARS1 levels | PROLV000595 | 0.62 | Protein levels | Vascular | 1 | 4 | 6 | 19 | |
| 1973 | Pain, back | MSKEL000033 | 0.62 | Musculoskeletal | Neural / glial | 43 | 4 | 8 | 31 | |
| 1974 | LCN2/PRTN3 ratio | PRORT001442 | 0.62 | Protein ratios | Myeloid | 25 | 3 | 10 | 13 | |
| 1975 | DBNL/PDGFB ratio | PRORT000868 | 0.62 | Protein ratios | Myeloid | 35 | 4 | 13 | 18 | |
| 1976 | ADAMTS16 levels | PROLV000033 | 0.62 | Protein levels | Myeloid | 3 | 1 | 2 | 10 | |
| 1977 | HHV7 U14 antibody | IMMUN000063 | 0.62 | Immunologic | Lymphocyte | 4 | 1 | 13 | 39 | |
| 1978 | TACC3 levels | PROLV001988 | 0.62 | Protein levels | Myeloid | 46 | 1 | 4 | 13 | |
| 1979 | Metabolic syndrome | METBL000015 | 0.62 | Metabolic | Neural / glial | 850 | 7 | 13 | 19 | |
| 1980 | RNF5 levels | PROLV001748 | 0.62 | Protein levels | Myeloid | 29 | 1 | 4 | 9 | |
| 1981 | FAM3C/NECTIN2 ratio | PRORT001115 | 0.62 | Protein ratios | Vascular | 19 | 1 | 12 | 10 | |
| 1982 | NTRK3 levels | PROLV001448 | 0.62 | Protein levels | Myeloid | 68 | 2 | 4 | 7 | |
| 1983 | Insulin levels | METBL000040 | 0.62 | Metabolic | Hepatocyte | 83 | 1 | 4 | 8 | |
| 1984 | Peripheral neuropathy | NEURO000032 | 0.62 | Neurologic | Neural / glial | 38 | 2 | 4 | 8 | |
| 1985 | GRSF1 levels | PROLV000936 | 0.62 | Protein levels | Myeloid | 3 | 3 | 9 | 10 | |
| 1986 | GDI2 levels | PROLV000871 | 0.62 | Protein levels | Hepatocyte | 0 | 4 | 12 | 35 | |
| 1987 | Cirrhosis | HPBIL000006 | 0.61 | Hepatopancreatobiliary | Neural / glial | 9 | 2 | 1 | 4 | |
| 1988 | Basal metabolic rate | METBL000007 | 0.61 | Metabolic | Neural / glial | 298 | 6 | 10 | 20 | |
| 1989 | MCAM/NCAM1 ratio | PRORT001505 | 0.61 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 1990 | CD40/TIMP3 ratio | PRORT000446 | 0.61 | Protein ratios | Vascular | 9 | 1 | 4 | 7 | |
| 1991 | Open wound | DERMA000043 | 0.61 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 1992 | Amino acid metabolites | METAB000002 | 0.61 | Metabolites | Neural / glial | 0 | 0 | 7 | 11 | |
| 1993 | ACAN levels | PROLV000010 | 0.61 | Protein levels | Stromal / connective | 76 | 3 | 7 | 17 | |
| 1994 | Fatty acids, docosahexaenoic acid | LIPID000020 | 0.61 | Lipids | Hepatocyte | 789 | 4 | 9 | 16 | |
| 1995 | ACYP2 levels | PROLV000022 | 0.61 | Protein levels | Hepatocyte | 0 | 3 | 6 | 17 | |
| 1996 | CHRDL2 levels | PROLV000434 | 0.61 | Protein levels | Adipose | 0 | 1 | 6 | 14 | |
| 1997 | Consultant specialty, general surgery | MISCL000017 | 0.61 | Miscellaneous | Neural / glial | 3 | 2 | 4 | 10 | |
| 1998 | FOXO3/SH2B3 ratio | PRORT001179 | 0.61 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 21 | |
| 1999 | Hip circumference | BMORP000011 | 0.61 | Body morphology | Neural / glial | 496 | 4 | 9 | 26 | |
| 2000 | ENG/TNFSF10 ratio | PRORT001021 | 0.61 | Protein ratios | Hepatocyte | 103 | 3 | 12 | 18 |